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Methionine Metabolism in Yucatan Miniature Swine 
 
Methionine is an essential amino acid which when not incorporated into protein, can be 
converted to S-adenosylmethionine, the universal methyl donor in over 200 
transmethylation reactions, that include creatine and phosphatidylcholine (PC) synthesis, 
as well as deoxyribonucleic acid (DNA) methylation.  Following transmethylation, 
homocysteine is formed which can be converted to cysteine via transsulfuration or 
remethylated to methionine by receiving a methyl group from folate or betaine.  Changes 
to methyl group availability in utero can lead to permanent changes in epigenetic patterns 
of DNA methylation which has been implicated in “fetal programming,” a phenomenon 
associated with poor nutrition during fetal development that results in low birth weight 
and disease in later life.  It has been shown that programming can also occur in the 
neonate. So our global objective was to understand how the variability of nutrients 
involved in methionine metabolism can affect methionine and methyl group availability.  
We hypothesize that nutrients that converge on methionine metabolism can affect 
methionine availability for its various functions.  In this thesis, we used intrauterine 
growth restricted (IUGR) piglets to investigate whether a global nutritional insult in utero 
can lead to a perturbed methionine metabolism.  Our results demonstrate that IUGR 
piglets have a lower capacity to dispose of homocysteine via both transsulfuration and 
remethylation pathways, as well as a lower incorporation of methyl groups into PC.  The 
second objective of this thesis was to determine whether variation in methionine supply 
and demand can affect methionine availability.  We demonstrated that stimulating either 
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acute or chronic creatine synthesis leads to lower methyl incorporation into protein and 
PC in pigs.  Furthermore, when methionine is limiting, supplementation with either folate 
or betaine leads to higher methionine availability for protein synthesis.  Lastly, because 
creatine is increasingly being utilized as an ergogenic and neuroprotective supplement, 
we wanted to determine whether provision of the creatine precursor, guanidinoacetate 
(GAA), could effectively increase tissue creatine stores.  We showed that 2.5 weeks of 
supplementation with GAA is more effective than creatine at increasing hepatic and 
muscle creatine stores.  The results of this thesis demonstrate that the presence of IUGR, 
an increased demand for creatine synthesis or the supplementation with remethylation 
nutrients can each affect methionine availability; all are important when considering 
neonatal nutrient requirements.  Furthermore, although GAA is effective at increasing 
levels of tissue creatine, higher GAA methylation can limit methionine availability for 
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Chapter 1: Introduction 
1.1 Introduction 
Methionine is an essential amino acid which, in addition to protein synthesis, serves 
several other important functions in the body including provision of a methyl group in 
transmethylation reactions to produce products such as creatine and phosphatidylcholine 
(PC).  Although essential in the diet, methionine can be remethylated following the 
donation of its methyl group by receiving a methyl group from folate or betaine, allowing 
methionine to “cycle” through transmethylation and remethylation.  Alternatively, 
following donation of its methyl group methionine can be used to form the amino acids 
cysteine and taurine by entering the transsulfuration pathway.  Methionine metabolism in 
the neonate is of particular importance due to growth and expansion of transmethylation 
products as well as the methylation of deoxyribonucleic acid (DNA).  Nutritional deficits 
during critical stages of early development can lead to permanent changes in DNA 
methylation which are associated with disease in later life.  This chapter will give a 
detailed description of methionine metabolism while highlighting the function of the 
nutrients involved in these pathways (Figure 2.1).   
1.2 Transmethylation  
Methionine is an essential amino acid containing a stable terminal methyl group bonded 
covalently to a sulfur atom.  When not incorporated into protein, methionine can be 
activated via conjugation of sulfur with adenosine via methionine adenosyltransferase 
(MAT) to form the “activated” S-adenosylmethionine (SAM) (Cantoni, 1951).  Although 
  2 
this reaction is ubiquitous, MAT activity is 20-400 fold higher in the liver than in other 
organs such as kidney and pancreas (Eloranta, 1977).  Due to the addition of adenosine, 
the methyl group of SAM is labile and is transferred in over 50 transmethylation reactions 
(Schubert et al., 2003).  The most quantitatively important of these methylation pathways 
involves the synthesis of PC, creatine and sarcosine via  phosphatidylethanolamine N-
methyltransferase (PEMT), guanidinoacetate methyltransferase (GAMT), and glycine N-
methyltransferase (GNMT), respectively (Mudd et al., 2007).  SAM also serves to 
methylate DNA via DNA methyltransferase (DNMT), although the quantitative 
significance of this reaction is unknown. 
After donating its methyl group, SAM is converted to S-adenosylhomocysteine (SAH) 
which is further hydrolyzed to homocysteine and adenosine via SAH hydrolase. Because 
the hydrolysis of SAH is a reversible reaction favoring homocysteine and adenosine 
condensation, the removal of hydrolysis products is imperative to prevent an 
accumulation of SAH (La Haba & Cantoni, 1959).  Experiments using perfused rat livers 
demonstrated that addition of homocysteine and adenosine led to a lower ratio of 
SAM/SAH and a subsequent reduction of methyl incorporation into DNA and PC 
(Hoffman et al., 1979).  The SAM/SAH ratio is thought to be an indicator of 
transmethylation potential, as SAM is required for and SAH is an inhibitor of 
transmethylation reactions, although each methyltransferase enzyme responds differently 
(Hoffman et al., 1980).  
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1.3 Transsulfuration and remethylation 
Following transmethylation and hydrolysis of SAH, there are three primary fates for 
homocysteine: 1) remethylation to form methionine; 2) catabolism to form cysteine via 
the transsulfuration pathway; and 3) release from the cell into the plasma.   
1.3.1Remethylation: Betaine-Homocysteine methyltransferase and methionine synthase 
Homocysteine can be methylated to reform methionine by accepting a methyl group from 
either betaine via betaine-homocysteine methyltransferase (BHMT) or from folate via 
methionine synthase (MS).  Betaine can either be consumed in the diet or endogenously 
synthesized via oxidation of choline following transport into the mitochondria (Kaplan et 
al., 1993). Choline dehydrogenase and betaine aldehyde dehydrogenase are co-localized 
in the mitochondria and carry out the 2 step conversion of choline to betaine (Chern & 
Pietruszko, 1999), which subsequently diffuses into the cytoplasm (Porter et al., 1993).  
Betaine functions in the cytosol as both an osmolyte (Häussinger, 1996) and as a methyl 
donor to reform methionine via BHMT (Finkelstein et al., 1972).  BHMT is a cytosolic 
zinc metalloenzyme (Millian and Garrow, 1998) that is primarily active in the liver of 
most species with low levels of activity also found in the kidney of humans and pigs 
(Finkelstein, 1990; Garrow, 1996; McKeever et al., 1991). 
Alternatively, folate, in the form of 5-methyltetrahydrofolate (5-methyl-THF), can 
function to provide a methyl group to reform methionine via MS which is found in all 
tissues.  Folate is consumed in the diet primairly as a polyglutamate derivative and is 
enzymatically converted via conjugase to an absorbable monoglutamate form, which is 
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further converted to 5-methyl-THF in the intestinal mucosa (Olinger et al., 1973).  Using 
vitamin B12 as a cofactor, 5-methyl-THF provides the methyl group for MS to reform 
methionine from homocysteine, also yielding tetrahydrofolate (THF) (Fujii et al., 1977).  
Using serine as a methyl source, THF is converted via serine hydroxymethyltransferase to 
5,10-methylenetetrahydrofolate (5,10-THF) (Davis et al., 2004; Motokawa and Kikuchi, 
1971), which can be converted back to 5-methyl-THF via methylenetetrahydrofolate 
reductase (Kutzbach & Stokstad, 1971), completing the folate cycle.  Folate is also 
required for purine synthesis which is important in the synthesis of DNA.  Moreover, 
maternal folate status is also important in the prevention of neural tube defects (Scott, 
1999).  Although the activity of MS is highest in the liver, the enzyme is ubiquitous with 
high levels of activity also found in the kidney, brain and pancreas (Brosnan et al., 2009;  
Finkelstein et al., 1971).   
1.3.2 Transsulfuration 
The transsulfuration pathway initiates with the irreversible condensation of serine and 
homocysteine to form cystathionine via cystathionine β-synthase (CBS) which uses 
vitamin B6 as a cofactor (Finkelstein & Chalmers, 1970).  Cystathionine is then converted 
to cysteine via cystathionine γ-lyase (CGL), which has low activity in the neonate 
(Zlotkin and Anderson, 1982).  In addition to use in protein synthesis, cysteine can be 
further metabolized to taurine by a two enzyme system (Nakamura et al., 2006; Stipanuk 
et al., 2002).  The transsulfuration enzymes show high activity levels in the liver but are 
also found in the kidney, pancreas, intestine and brain (Mudd et al., 1965).   
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1.3.3 Regulation of homocysteine metabolism 
There has been considerable research examining the regulation of homocysteine 
remethylation via folate and betaine.  In rats, remethylation is favoured over 
transsulfuration based on the Km values for homocysteine in rat liver for BHMT and MS, 
which are 0.012-0.06 mM and 0.06 mM, respectively, while the Km for the 
transsulfuration enzyme CBS is 1-25 mM (Finkelstein and Martin, 1984).  In vitro studies 
using rat livers demonstrated that under standard dietary conditions, both remethylation 
pathways contribute equally to the reformation of methionine (Finkelstein & Martin, 
1984).  Interestingly, the percentage of total methionine flux contributed by remethylation 
and transsulfuration are roughly equal in 1-week old piglets, while 3-week old piglets 
have a 4 fold higher proportion of methionine flux via transsulfuration compared to 
remethylation, as well as lower total flux through both pathways (Bauchart-Thevret et al., 
2009).  Because the absolute rates of protein synthesis are the same at both 1 and 3 weeks 
old, it appears that neonates have a higher methionine demand for transmethylation 
reactions which is sustained via an increased rate of remethylation (Bauchart-Thevret et 
al., 2009).  Furthermore, human studies have demonstrated that neonates have a higher 
methionine cycle activity compared to adults (Thomas et al., 2008). The activity of 
BHMT is high in the neonatal rat until 3 weeks of age and it declines to a plateau by week 
4 (Clow et al., 2008). Due to the maturity of the pig at birth compared to the rat, this 
result is in keeping with the high rates of remethylation found in the neonatal pig 
(Bauchart-Thevret et al., 2009).  Alternatively, developmental changes in MS activity are 
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organ-specific, making it difficult to draw conclusions on the contribution of MS to 
higher neonatal rates of remethylation (Thompson et al., 2001). 
It has been suggested that under normal dietary conditions, MS is the primary 
remethylation pathway and BHMT functions in a secondary capacity during times of 
methionine deficiency (Kim et al., 2005; Park and Garrow, 1999) or excess (Finkelstein et 
al, 1971).  Methionine deficient rats receiving adequate betaine have BHMT activity and 
BHMT mRNA levels ~4 fold higher than rats receiving adequate methionine and ~8 fold 
higher than betaine and methionine deficient rats (Park and Garrow, 1999).  Activity is 
unaffected (Park & Garrow, 1999) or less affected (Finkelstein et al., 1983) by moderate 
choline supplementation of a methionine adequate diet.  Because the degree of 
methionine deficiency is proportional to the increase in BHMT activity when combined 
with provision of methyl donors, remethylation via BHMT appears to function to 
conserve methionine when it is limiting (Park and Garrow 1999); however, it is possible 
that these effects are species specific, as experiments in pigs demonstrate a modest 30% 
increase in BHMT activity following of betaine to a methionine deficient diet (Emmert et 
al., 1998).  Furthermore, neither methionine deficiency nor betaine supplementation to a 
methionine adequate diet had an effect on hepatic BHMT activity in pigs (Emmert et al., 
1998). 
MS activity is also higher during situations with an increased need for methionine 
synthesis, such as with low dietary protein (Finkelstein et al., 1971).  Similar to the 
benign effect of choline supplementation on BHMT activity, folate supplementation in 
rats, leading to ~4 fold higher plasma folate, showed no effect on hepatic MS activity 
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(Achón et al., 2007).  Both SAM and SAH are regulators of homocysteine metabolism, 
with SAM exhibiting an inhibitory effect on BHMT and MS activity, and SAH positively 
affecting activity of these enzymes  (Finkelstein & Martin, 1984; Finkelstein & Martin, 
1986; Kutzbach & Stokstad, 1971).  Although both enzymes are also regulated by 
methionine excess, methionine supplementation in rats leads to higher activity levels of 
both BHMT and CBS, while MS activity is lower (Finkelstein & Martin, 1986).  
Similarly, a high protein diet also results in higher BHMT activity while MS is repressed 
(Finkelstein et al., 1971).   
Although these experiments provide valuable insight into methionine metabolism, the 
regulation of remethylation and transsulfuration is organ specific (Finkelstein, 2007), and 
the quantification of hepatic enzyme activities and metabolite concentrations do not 
necessarily represent whole body remethylation metabolism.  Although the liver is the 
primary site for methionine utilization, other organs also contribute significantly to 
methionine metabolism, such as the pancreas which exports more endogenously 
synthesized methionine than the liver as well as a comparable amount of homocysteine 
(Wilson et al., 2009).  In the piglet, the gastrointestinal tract metabolizes ~20% of dietary 
methionine, one third of which is utilized for cysteine synthesis (Riedijk et al., 2007), 
suggesting an intact transsulfuration pathway.  Because methionine metabolism is highly 
variable among tissues, it is important to consider whole body methionine metabolism 
when determining the relative contribution of folate and betaine to remethylation.    
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Supplementation of either folate or betaine have the capacity to lower plasma 
homocysteine (Keser et al., 2013; McRae, 2013) and fasting plasma homocysteine shows 
a strong inverse relationship with plasma folate. Moreover, post methionine load levels of 
homocysteine have a strong inverse relationship with plasma betaine (Holm, 2004), 
which is in keeping with the theory that BHMT functions to dispose of excess 
methionine.  BHMT knockout mice fed a standard chow diet have higher levels of plasma 
homocysteine (Teng et al., 2012).  Folate deficient rats also demonstrate elevated levels 
of homocysteine, highlighting the importance of both BHMT and MS for remethylation 
(Miller et al., 1994).  Experiments involving in vivo comparisons of whole body 
remethylation via these two nutrients are currently lacking in the literature.   
1.3.4  Choline and betaine 
Choline and betaine can both be synthesized endogenously or consumed in the diet.  
Some dietary sources of choline are eggs, beef and wheat germ, while foods high in 
betaine include wheat bran, wheat germ and spinach.  The recommended adequate intake 
of choline by the Institute of Medicine is 550 mg/day and 425 mg/d for men and women 
respectively, with an adequate intake of 550 mg/day during pregnancy (1998). An ad 
libitum intake study in the US reported choline intakes averaging 6.7 and 8.4 mg/kg per 
day for women and men, respectively (Fischer et al., 2005).  Although there is no 
recommended daily intake for betaine, intake was reported to be 4.7 and 5.3 mg/kg per 
day for women and men, respectively (Fischer et al., 2005).  
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The total choline concentration in mature breast milk is ~1500 µM consisting of ~35% 
from each of glycerophosphocholine and phosphocholine and ~15% from each of free 
choline and PC.  Free choline in serum is higher in breast fed compared to formula fed 
infants and the choline concentration of breast milk is influenced by maternal choline 
status (Ilcol et al., 2005).  Infant formula ranges from 700 µM in soy-derived formula to 
1800 µM in bovine milk-derived formula and consists mostly of glycerophosphocholine 
(Holmes-McNary et al., 1996).  Because the betaine concentration in breast milk is only 7 
µM (Fischer et al., 2010), the primary source of betaine in the infant is most likely 
derived from choline which is ~200 fold higher in breast milk than betaine.  In rats, ~85% 
of labelled dietary choline and phosphocholine is recovered as betaine in the liver within 
24 hours, while only ~50% and ~15% of PC and glycerophosphocholine, respectively, are 
converted to betaine after 24 hours (Cheng et al., 1996), demonstrating the variability of 
these choline derivatives as sources of betaine.  Choline is highly important during early 
development and studies have demonstrated the positive association of choline intake 
with cognitive development (Caudill, 2010; McCann et al., 2006; Meck & Williams, 
2003).     
1.3.5 Folate 
Folate, found in supplements and used to fortify food, is primarily in the monoglutamate 
form while naturally occurring folate in foods, such as leafy green vegetables as well as 
some fruits and beans, is in the reduced polyglutamate form.  In 1998, the USA and 
Canada implemented folic acid fortification in a variety of foods including breads and 
cereals in an attempt to reduce neural tube defects.  Although the incidence of neural tube 
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defects has lowered, it has been suggested that fortification could be leading to an excess 
of folate in the diet (Lucock & Yates, 2009; Osterhues et al., 2013).   
Approximately 28% of Canadian females between 6 and 79 years of age take a folate 
containing supplement; however, supplementation is lowest among teenagers and young 
adults (Colapinto et al., 2012).  The average total folate concentration in breast milk is 
~80 ng/mL (Smith et al., 1985) and the current global recommendation for the minimum 
level of folic acid in infant formula is 60 ng/mL (Koletzko et al., 2005).  Unlike choline, 
breast milk folate levels are independent of maternal folate status with no correlation 
between milk folate concentration and maternal blood folate indexes in women 
supplemented with folate (Smith et al., 1985).  In the piglet, it has been shown that folate 
can be synthesized by the intestinal microflora at a rate between 93-176 nmol/day which 
is roughly 34-65% of the daily requirement (Kim et al., 2004).  It is thought that ~15% of 
folate synthesized in the colon of the piglet is absorbed (Asrar and O'Connor, 2005), 
suggesting bacterial folate synthesis provides ~5-10% of the piglet requirement.   
1.4 Transmethylation demand  
In addition to GAMT and PEMT, the enzyme GNMT is also known to be a quantitatively 
significant consumer of methyl groups by methylating glycine to form sarcosine.  Dietary 
methionine supplementation leads to a dose dependent increase in GNMT activity 
(Rowling et al., 2002), and it is thought that GNMT functions in an overflow pathway to 
regulate the SAM/SAH ratio and transmethylation reactions (Ogawa and Fujioka, 1982). 
GNMT knockout mice have elevated levels of both plasma SAM and methionine 
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(Martínez-Chantar, 2008) and develop hepatic steatosis via an increased flux through 
PEMT and a resulting increase in triglyceride synthesis (Martínez-Uña, 2013).   Early 
investigations of the quantitative significance of transmethylation reactions led to the 
suggestion that creatine is the primary methyl group consumer (Mudd and Poole, 1975); 
however, this notion was refuted by Jacobs et al. (2005) who calculated a 2-3 fold  higher 
SAM utilization by PEMT versus GAMT.  Experiments in PEMT knockout mice 
demonstrate ~50% lower levels of homocysteine after 3 weeks, highlighting the 
significant demand of PEMT for SAM (Noga and Vance, 2003).  Although these 
transmethylation reactions have been assessed independently, there appear to be no in 
vivo studies directly comparing SAM utilization among transmethylation reactions (Mudd 
et al., 2007).      
1.4.1 Phosphatidylcholine synthesis 
The synthesis of PC via PEMT involves the sequential transfer of 3 methyl groups to 
phosphatidylethanolamine (PE) to produce PC (Ridgway and Vance, 1987).  PC is 
important for bile and lipoprotein synthesis and quantitatively, the entire hepatic pool of 
PC is secreted in bile each day (Walkey et al., 1998).  PC synthesis is also required for the 
hepatic secretion of VLDL (Yao and Vance, 1988).  There appears to be a higher demand 
for PC for lipoprotein synthesis than for bile, as 5 hours after injection of [methyl-
3
H]methionine into the tail vein of mice, 2-3% of radioactivity is found in bile, while 5-
7% is found in plasma (Noga and Vance, 2003).   
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The PEMT pathway is responsible for approximately 30% of hepatic PC biosynthesis, 
with the remainder synthesized by the Kennedy pathway via the enzyme CDP-
choline:1,2-diacylglycerol cholinephosphotransferase, which transfers phosphocholine to 
1,2-diacylglycerol  (Li and Vance, 2008).  While the Kennedy pathway is ubiquitous, 
PEMT activity is primarily localized to the liver (Cui et al., 1993).  PC can be 
metabolized to choline and during choline deprivation, choline recycling can occur by 
increasing PEMT activity via an increase in PE concentration during short term 
deficiency (Ridgway et al., 1989) or via an upregulation of PEMT expression during 
prolonged deficiency (Cui & Vance, 1996).  The synthesis of PC via the Kennedy 
pathway is 3 fold higher when PEMT is inhibited demonstrating the coordinated 
regulation of PC synthesis (Pritchard & Vance, 1981).   
1.4.2 DNA methylation 
Another important methyltransferase is DNMT which transfers a methyl group to 
cytosine residues in CpG dinucleotides of DNA.  DNA methylation is an example of an 
epigenetic alteration, which is a heritable modification of gene expression that does not 
involve alterations to the DNA sequence (Hanley et al., 2010).  These modifications can 
occur in large regions of DNA such as repetitive DNA, or can be localized to promoter 
regions of DNA.  Patterns of DNA methylation are established during early development 
and epigenetic changes near promoter regions of DNA can lead to changes in gene 
expression via direct effects on transcription factors or indirectly via repressor protein 
bindng  (Reamon-Buettner et al., 2014; Tate and Bird, 1993).  
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1.4.3 Epigenetics and fetal programming in IUGR 
Epigenetic changes to DNA methylation have been implicated in the fetal origins 
hypothesis, which was first proposed by David Barker to describe how an insult to the 
fetus can result in permanent negative health effects in later life (McMillen and Robinson, 
2005).  This hypothesis was originally based on epidemiological studies which 
demonstrated an association between low birth weight and disease in later life (Barker 
and Osmond, 1986; Barker et al., 1989; Gluckman et al., 2008; Godfrey and Barker, 
2000).  Intrauterine growth restriction (IUGR) is a term used to describe a fetus with a 
body weight that is lower than the 10
th
 percentile for gestational age, which is defined as 
less than 2.5 kg for a term infant (Ferenc et al., 2014; WHO, 1995); after correction for 
factors such as low maternal weight, the incidence of IUGR is 4-7% (Vandenbosche and 
Kirchner, 1998).  The etiology of IUGR encompasses a variety of factors, including 
smoking and preeclampsia (Campbell et al., 2012) and it is thought that placental 
insufficiency is central to most cases of IUGR (Figueras and Gardosi, 2011).  It has been 
well established in both human and animal models that IUGR can lead to an increased 
risk for hypertension, cardiovascular disease, diabetes and obesity in later life (McMillen 
& Robinson, 2005).  Recent work using Yucatan miniature pigs has demonstrated that 
IUGR pigs experience catch-up growth, and develop early markers for hypertension 
(Myrie et al., 2011), dyslipidemia and obesity (Myrie et al., 2008). It has also been 
demonstrated that a diet high in salt, sugar and fat exacerbates metabolic syndrome 
outcomes (Myrie et al., 2012).   
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Recently, this ‘programming’ appears to be mediated by epigenetic modifications, in 
particular, the altered pattern of gene expression resulting from altered DNA methylation 
(McMillen & Robinson, 2005).  It has further been demonstrated that the dietary methyl 
supply can play a role in the programming process (Lillycrop et al., 2005).  In a study by 
Sinclair et al. (2007), sheep fed a methyl deficient diet for 8 weeks preconception and 6 
days post conception gave birth to male offspring that were insulin resistant with elevated 
blood pressure.  Analysis of genome methylation suggested that this was due to decreased 
methylation.  Alternatively, maternal folate supplementation during gestation can also 
lead to site specific changes in DNA methylation, as well as changes in gene expression 
in mice (Barua et al., 2014).  
Reprogramming has also been demonstrated to extend to the neonatal phase as well.  
Neonatal overfeeding of rats can lead to promoter specific changes in methylation of the 
promoter region of the anorexigenic neurohormone proopiomelanocortin, the expression 
of which impacts food intake and body weight (Plagemann et al., 2009).  Furthermore, 
rats fed a folate deficient diet from weaning until 8 weeks of age, followed by a control 
diet, had an increase in genomic DNA methylation compared to control or folate 
supplemented rats, demonstrating the importance of folate intake during early 
development (Kotsopoulos et al., 2008).   
It has been hypothesized that an imbalance of dietary methionine in relation to other 
amino acids may also play a role in the programming of disease (Langley-Evans, 2000; 
Rees et al., 2006).  Although many of the experiments examining the effect of altered 
methyl supply on fetal programming have focused on the provision of folate, as discussed 
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in previous sections, the metabolic pathways that converge on methionine metabolism are 
closely linked.  Because of the variable levels of nutrients in neonatal diets, more research 
is needed to determine the effect of these different levels of nutrients on methionine 
metabolism and availability.   
1.4.4 Creatine synthesis  
Creatine synthesis involves 2 steps, commencing in the kidney with the production of 
guanidinoacetate (GAA) and ornithine via the transfer of the amidino group from arginine 
to glycine by arginine:glycine amidinotransferase (AGAT) (Bloch and Schoenheimer, 
1941).  This reaction is followed by the SAM dependent methylation of GAA in the liver 
via GAMT to produce creatine and SAH (Cantoni & Vignos, 1954).  Creatine 
supplementation leads to lower AGAT activity (Walker, 1960) as well as lower levels of 
AGAT mRNA and protein (McGuire et al., 1984), thus demonstrating that creatine 
synthesis is regulated via GAA production.  Furthermore, creatine supplementation has 
been shown to lower plasma homocysteine in rats (Deminice et al., 2011; Stead et al., 
2001) which suggests a lower production of GAA; however, several studies in humans 
have demonstrated no effect of creatine supplementation on levels of plasma 
homocysteine (Steenge & Verhoef, 2001; Taes et al., 2004).  These differences may be 
attributed to the lower renal production of GAA by humans compared to rats (Edison et 
al., 2007).   
In contrast, creatine supplementation has no effect on GAMT activity, and creatine 
synthesis has been shown in rats to be proportional to GAA availability (Da Silva et al., 
  16 
2009).  Human studies have also demonstrated a dose response effect of GAA 
supplementation on the plasma levels of both GAA and creatine, as well as a higher 
concentration of plasma homocysteine with GAA supplementation (Ostojic et al., 2013).  
Furthermore, GAA has also been used as a means to increase methylation demand (Kharb 
et al., 2014).  
1.4.5 Creatine metabolism 
In addition to endogenous synthesis, creatine can be consumed in the diet and is primarily 
found in animal products such as red meat and fish.  Approximately 1.7% of total creatine 
is excreted as creatinine each day (Wyss & Kaddurah-Daouk, 2000) and the typical 20-39 
year old adult consumes 7.9 mmol and 5.0 mmol of creatine for men and women 
respectively, which accounts for replenishing approximately half of daily creatine loss 
(Stead et al., 2006).  In the body, the enzyme creatine kinase utilizes ATP to 
phosphorylate creatine to form creatine phosphate.  The reversibility of this reaction 
allows creatine phosphate to function as an energy buffer by synthesizing ATP during 
times of high energy demand (Wallimann et al., 1992).  Tissue stores of creatine and 
creatine phosphate are highest in skeletal muscle, heart and brain, due to the high energy 
requirement and utilization of ATP in these tissues  (Horn et al., 1998; Ipsiroglu et al., 
2001).   
Following hepatic synthesis, creatine is released from the liver into the blood and 
transported into tissues against a concentration gradient via the sodium and chloride 
dependent creatine transporter (SLC6A8), which is specific for the amidine group and is a 
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saturable process (Fitch and Shields, 1966; Loike et al., 1986).  Because creatine is 
arguably the most effective ergogenic nutritional supplement (Buford et al., 2007), 
several studies have focused on methods to increase creatine accretion, such as high 
carbohydrate consumption during supplementation (Green et al., 1996; Steenge and 
Verhoef, 2001).  Creatine is typically consumed at doses up to 20 g/day by individuals 
who wish to improve exercise or sports performance (Bemben and Lamont, 2005; 
Terjung et al., 2000).  Furthermore, creatine has recently been proposed as a therapeutic 
agent for a variety of neurodegenerative conditions including Parkinson’s disease (Bender 
et al., 2008) and Huntington’s disease (Hersch et al., 2006) as well as a potential 
neuroprotectant (Peña-Altamira et al., 2005).  The agriculture industry has also 
investigated creatine as a potential food additive due to its demonstrated capacity to 
increase tissue stores of phosphocreatine (Lindahl et al., 2006) and increase weight gain 
(Young et al., 2005).  Interestingly, creatine supplementation can lead to downregulation 
of the creatine transporter as a negative feedback mechanism to control intracellular 
creatine levels (Guerrero-Ontiveros & Wallimann, 1998). 
GAA has also recently gained attention as a potential supplement to increase creatine 
stores in humans and livestock (Baker, 2009); however, research in this area is currently 
limited.  A recent clinical trial investigating the effect of a 6 week supplementation period 
with 24 g/day of GAA demonstrated an increase in plasma creatine and a low incidence 
of biochemical abnormalities (Ostojic et al., 2013).  Higher levels of creatine as well as 
improvements in breast meat yield and gain:feed ratio have been reported in broiler 
chickens fed a vegetable based diet supplemented with GAA (Michiels et al., 2012).  
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1.4.6 Creatine in the neonate 
Total body creatine in the neonatal piglet increases by ~70% during the period from 4 to 
11 days of age demonstrating the high demand for creatine during early development 
(Brosnan et al. 2009).  The neonatal pig receives 25% of its creatine requirement from the 
sow’s milk and consequently must synthesize the majority of its creatine needs (Brosnan 
et al., 2009).  A recent analysis of breast milk and infant formula determined a wide 
variability in the creatine concentration with values of 330 µM in standard infant formula 
and 10 µM in soy-based formula (Edison et al., 2013).  The contribution between dietary 
and endogenously synthesized creatine in the infant is variable with breast-fed infants 
receiving ~10% of their creatine from diet while infants receiving cow milk-based 
formulas consume ~35% of their total creatine via diet (Edison et al., 2013).  
Furthermore, infants fed soy-based formula consume negligible amounts of dietary 
creatine, thus requiring synthesis of the entire creatine requirement.  This inconsistency in 
infant dietary creatine intake translates into variability in the demand for creatine 
synthesis, which consequently creates a variable demand for methyl groups.  This is 
important during early development, as the neonate appears to have a high demand for 
transmethylation reactions (Bauchart-Thevret et al., 2009).   
 
1.5 Methionine sparing 
Several studies have demonstrated that the provision of excess cysteine can spare the 
methionine requirement by up to 40% (Fukagawa, 2006; Shoveller et al., 2003a), and the 
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concept of folate, betaine and creatine functioning to spare methionine has been 
previously proposed (Fukagawa, 2006).  Betaine has been shown to spare methionine in 
chickens (Dilger et al., 2007); however, experiments in pigs concluded that supplemental 
betaine cannot replace dietary methionine (Matthews et al., 2001).  Creatine and GAA 
have also been considered as having potential in agriculture to spare both methionine and 
arginine; when added to an arginine-deficient diet, both GAA and creatine 
supplementation in chicks resulted in a higher gain:feed ratio (Dilger et al., 2013).  More 
research is needed using more precise techniques to determine whether these nutrients can 
indeed spare methionine for growth, especially in mammalian species. 
1.6 Pig as model for human 
There are several factors that make the pig an excellent model to examine amino acid 
metabolism and IUGR.  The nutrient requirements of the piglet resemble those of the 
human more so than any other non-primate mammalian species, especially with respect to 
amino acids (Miller and Ullrey, 1987).  Similar to the human, pigs have a long gestation 
time and organ systems are similarly developed at birth (Guilloteau et al., 2010).  
Furthermore, fetal pigs have an amino acid composition similar to humans which 
demonstrates the pig is an ideal model to study amino acid metabolism during early 
development (Wu et al., 1999).    
Research methodologies for investigating amino acid metabolism have also been well 
established in the pig.  Specifically, the methionine requirement of the piglet has been 
determined both parenterally and enterally with either excess or deficient levels of dietary 
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cysteine (Shoveller at al., 2003b).  The indicator amino acid oxidation technique used to 
determine amino acid requirements has been used extensively in pigs. It is based on the 
principle that if the amount of a limiting amino acid is increased incrementally while 
determining the rate of phenylalanine oxidation at each test level, phenylalanine oxidation 
will eventually plateau, indicating the maximum amount of phenylalanine that has been 
incorporated into protein and the test amino acid is no longer limiting (Bertolo et al., 
2005; Elango et al., 2002; House et al., 1998).  The runt pig, defined as less than 65% of 
the average weight of the littermates (Hegarty & Allen, 1978), is assumed to have 
suffered a global nutritional insult in utero as compared to its littermates; this 
spontaneous IUGR piglet model has been successfully used to study fetal programming 
(Ferenc et al., 2014; Guilloteau et al., 2010; Myrie, 2011).  The Yucatan miniature pig has 
been used in our lab to study intestinal dipeptide uptake (Nosworthy et al., 2013), short 
bowel syndrome (Dodge et al., 2012) and parenteral nutrition (Alemmari et al., 2012). 
Furthermore, this model has been used by our lab to demonstrate compensatory growth in 
IUGR pigs (McKnight, 2012) as well as fewer nephrons and higher diastolic blood 
pressure in adult IUGR pigs compared to normal weight pigs fed the same diet (Myrie, 
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1.7 Thesis rationale and hypotheses 
1.7.1 Rationale 
Although the methionine requirement has been determined in the human infant and piglet, 
it has been shown that variability in the nutrients involved in methionine metabolism can 
affect the methionine requirement.  Furthemore, it has been proposed that an imbalance of 
sulfur amino acids during early development may play a role in fetal programming.  
Because IUGR piglets have been used as a model for fetal programming, this research 
was conducted to determine whether IUGR piglets have altered methionine metabolism.  
We also wanted to determine whether changes in the availability or demand of nutrients 
involved in methionine metabolism can impact methionine availability during early 
development.  The primary objectives of this thesis are 1) to determine whether IUGR 
piglets have perturbed methionine metabolism; 2) to determine whether an increased 
methylation demand for one product can limit methionine availability for protein 
synthesis and other transmethylation reactions; and 3) to determine whether the nutrients 
folate, betaine and creatine can affect the availability of methionine for protein synthesis.    
1.7.2  Hypotheses 
We hypothesize that 1) IUGR piglets will have perturbed methionine metabolism 
compared to normal weight littermates; 2) increasing the demand for creatine synthesis in 
the neonatal piglet will limit methionine availability for protein synthesis and other 
transmethylation reactions; and 3) provision of folate, betaine or creatine will increase 
availability of methionine for protein synthesis. 
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2.1 Abstract  
Intrauterine growth restriction (IUGR), in both animals and humans, has been linked to 
metabolic syndrome later in life. There has been recent evidence that perturbations in 
sulfur amino acid metabolism may be involved in this early programming phenomenon. 
Methionine is the precursor for cellular methylation reactions and for the synthesis of 
cysteine. It has been suggested that the mechanism behind the “fetal origins” of adult 
diseases may be epigenetic, involving DNA methylation. Because we have recently 
demonstrated the fetal origins phenomenon in Yucatan miniature swine, we hypothesized 
that sulfur amino acid metabolism is altered in IUGR piglets. In this study metabolites 
and the activities of sulfur amino acid cycle enzymes were analyzed in liver samples of 3-
5-d-old runt (IUGR: 0.85 ± 0.13 kg) and large (1.36 ± 0.21 kg) Yucatan miniature pig 
littermates (n=6 pairs). IUGR piglets had significantly lower specific and total activities 
of betaine-homocysteine methyl transferase (BHMT) and cystathionine γ-lyase (CGL), 
than larger littermates (P<0.05). Expression of CGL (but not BHMT) mRNA was also 
lower in IUGR piglets (P<0.05). This low CGL reduced cysteine and taurine 
concentrations in IUGR pigs and led to an accumulation of hepatic cystathionine, with 
lower homocysteine concentrations. Methylation index and liver global DNA methylation 
were unaltered. Reduced prenatal growth in Yucatan miniature piglets impairs their 
remethylation capacity as well as their ability to remove cystathionine and synthesize 
cysteine and taurine, which could have important implications on long term health 





The “fetal origins” of adult disease hypothesizes that factors in utero can affect the 
development of disease later in life [1]. Many studies in both animals and humans have 
demonstrated links between prenatal growth rate and adult diseases, including obesity, 
cardiovascular diseases and type 2 diabetes [2]. Because the initial hypotheses generated 
from epidemiological data implicated small birth weight, the most successful animal 
model in fetal programming has been the protein-deficient rat dam [3]. The intrauterine 
growth-restricted (IUGR) rat pups became adult rats that exhibited symptoms of various 
chronic diseases such as obesity, coronary heart disease, hypertension, glucose 
intolerance, appetite dysregulation and osteoporosis [3]. In addition, postnatal catch-up 
growth in growth retarded pups also led to reduced longevity and increased hypertension, 
similar to epidemiological data [4]. Recently, the protein-deficient rat dams were found to 
be hyperhomocysteinemic because the low protein diet was disproportionately high in 
methionine and low in cysteine (Figure 2.1) [5-7]. Hyperhomocysteinemia in pregnancy 
has been linked to intrauterine growth retardation [8] and hyperhomocysteinemia in 
children has been linked to development of obesity and hypertension [9]. Because the 
mediating mechanism of fetal programming does not seem to be protein deficiency per 
se, focus has been more recently directed toward imbalance of sulfur amino acid 
metabolism as a potential mechanism for this phenomenon. Indeed, Rees [7] concluded 




Methionine is required for protein synthesis and for oxidation to synthesize cysteine; the 
oxidation to cysteine involves both transmethylation and transsulfuration pathways 
(Figure 2.1). However, the oxidative enzymes in the transsulfuration pathway are low in 
utero and may be limiting for cysteine synthesis [10,11]. With intrauterine growth 
retardation, where nutrient flow to the fetus is reduced, oxidative pathways are further 
reduced due to less substrate availability. In the postnatal situation, compensatory growth 
following IUGR involves more efficient use of nutrients which, for amino acids, usually 
also involves a downregulation of oxidative pathways [12]. So, IUGR neonates have an 
imbalanced methionine metabolism such that oxidation, or transsulfuration, is reduced 
leading to a potential accumulation of homocysteine. 
One of the key transmethylation reactions is methylation of DNA, which is an inheritable 
mechanism regulating gene expression [13]. Indeed, such epigenetic changes have been 
proposed as the underlying mechanisms in the plasticity associated with early 
development which can plausibly program risk for disease in later life [13,14]. 
Methylation of DNA can be affected by dietary levels of methyl-donor components, such 
as methionine, choline and folate [13,15]. Moreover, in fetuses of rat dams fed 
methionine-imbalanced low protein diets, global methylation of DNA was increased in 
several tissues, including the fetal liver [6]. Thus, changes in sulfur amino acid 
metabolism have been suggested as a possible mechanism by which environmental 
influences during fetal development could permanently affect fetal nutrition [7].  
More recently, we [16,17] and others [18,19] have validated the pig as a model for early 






Figure 2.1  Schematic of pathways in sulfur amino acid metabolism. Abbreviations: 
MAT, methionine adenosyltransferase; SAHH, S-adenosylhomocysteine hydrolase; CBS, 
cystathionine β-synthase; CGL, cystathionine γ-lyase; MS, methionine synthase; BHMT, 
betaine:homocysteine methyltransferase; SHMT, serine hydroxymethyltransferase; 





 biomarkers for hypertension, diabetes, obesity and dyslipidemia early in adulthood, 
compared to larger siblings. The pig has distinct advantages over rodent models of this 
phenomenon in that postnatal metabolism can be studied and the nutritional requirements 
of the pig are more similar to those of the human, especially with respect to amino acids 
[20]. Therefore, using the Yucatan miniature piglet as a model, we hypothesized that the 
lowered fetal nutrition which caused the subsequent low birth weight of the runt would 
also result in a decrease in the activity of the enzymes that facilitate the removal of excess 
sulfur amino acids, such as methionine and homocysteine. The imbalanced metabolic 
pathways and accumulation of homocysteine would also modify the methylation of DNA, 
thereby affecting the long term regulation of gene expression and perhaps explaining the 
higher risk for chronic diseases later in life observed in IUGR piglets [16-19]. The main 
objectives of this study are: 1) to determine if IUGR limits the capacity of certain sulfur 
amino acid enzymes; 2) to determine if IUGR affects expression of altered sulfur amino 
acid enzymes; and 3) to determine if IUGR affects global methylation of DNA as a result 
of sulfur amino acid enzyme alterations. 
2.3 Methods and materials 
Reagents. L-[3-
14
C]serine was obtained from American Radiolabeled Chemicals, Inc. (St. 
Louis, MO) and 5-[
14
C]methyl-tetrahydrofolic acid, barium salt was from Amersham 







C-betaine) were acquired from Moravek Biochemicals 
(Brea, CA). The poly-prep pre-filled chromatography columns (AG 1-X8, AG1-X4, and 
AG50W-X4 resins, 200-400 mesh, 0.8 x 4 cm) were obtained from Bio-Rad Laboratories, 
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Inc. (Hercules, CA). All other chemicals were of analytical grade and were from Sigma 
(St. Louis, MO) or Fisher Scientific (Fair Lawn, NJ). 
Animals. Yucatan miniature piglets (n=12) were obtained from the Memorial University 
of Newfoundland breeding colony. Animal care and handling procedures were approved 
by the Institutional Animal Care Committee and in accordance with the guidelines of the 
Canadian Council on Animal Care. Six pairs of littermates, each consisting of a 
spontaneously occurring runt (3 male, 3 female) and its largest littermate (2 male, 4 
female), were removed from sows at 3-5 d of age. For the purposes of this study, a runt 
(i.e., IUGR) was defined as the smallest piglet in a litter that was at least 25% smaller 
than its largest littermate at birth. In this herd of Yucatan pigs, piglets fitting these 
parameters occur naturally in ~ 90% of litters. Within 1 h of removal from the sow, pigs 
were anesthetized with halothane and blood was sampled via cardiac puncture and 
centrifuged immediately at 1500×g for 10 min at 4°C to isolate plasma; since pigs were 
within 1.5-2 h of last suckling, piglets were in fed state. Organs (liver, kidneys, colon, 
small intestine, lung, and heart) were removed quickly under anesthesia, weighed and 
samples were immediately frozen in liquid nitrogen and stored at -80°C until further 
analyses. 
Liver homogenate preparation. Approximately 0.5-1.5 g of frozen liver was weighed and 
kept on ice. A homogenate of liver and 50 mM potassium phosphate dibasic (pH 7.0) 
buffer (1:5) was freshly prepared on ice using a Polytron homogenizer (Brinkmann 
Instruments, Mississauga, ON, Canada) for 30 s at 50% output. The homogenate was 
centrifuged at 20 000×g for 30 min at 4°C (Beckman L8 - M Ultracentrifuge) and the 
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supernatant was removed and used immediately to measure the activities of sulfur amino 
acid metabolism enzymes. Homogenates were centrifuged at 13 000×g for 5 min at 4°C. 
Protein concentration of homogenates was determined using the Biuret assay using 
porcine serum albumin as a standard. 
Metabolite analyses. Total homocysteine and cysteine concentrations [21], S-adenosyl-L-
methionine (SAM) and S-adenosyl-L-homocysteine (SAH) concentrations [22] and 
cystathionine concentrations [23] were determined by high-performance liquid 
chromatography (HPLC); all samples were first reduced with tris(2-
carboxyethyl)phosphine. Other amino acids were determined by reverse-phase HPLC 
using phenylisothiocyanate derivatives [24]. Plasma urea concentrations were determined 
using a spectrophotometric assay kit (Sigma Chemical Co., St. Louis, MO).  
Enzyme assays. We measured the activities of three enzymes involved in the 
remethylation of homocysteine to methionine—methionine synthase (MS), 
betaine:homocysteine methyltransferase (BHMT), and methylenetetrahydrofolate 
reductase (MTHFR)—and three enzymes involved in catabolism of methionine to 
cysteine—methionine adenosyltransferase (MAT), cystathionine β-synthase (CBS), and 
cystathionine γ-lyase (CGL). All assays were first demonstrated to be linear with respect 
to time (0-60 min) and protein concentration (0-2 mg). Specific activities were expressed 
as nmol of product per minute per mg protein. The hepatic enzyme capacity (nmol of 
product/min/kg body weight) was determined for each animal by multiplying the enzyme 
specific activity by the total protein content in the whole liver (ie mg protein/g wet liver × 
total liver weight) and correcting for body weight. Protein content of the liver was 
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determined using a combustion method (Application Note-154 for FP-528, LECO 
Instruments, Mississauga, ON, Canada) and analyzing for total elemental nitrogen; a 
factor of 6.25 g protein/g nitrogen was used to convert nitrogen to protein. Hepatic 
transglutaminase activity was measured using a colorimetric microassay as per kit 
instructions (Covalab – UK Ltd., Cambridge, UK). 
 Methionine synthase. MS was measured using an assay described by Koblin et al. [25]. 
Briefly, liver homogenate (100 μL of 2 mg/mL) was mixed with 100 μL substrate mixture 
(20 μM cyanocobalamin, 58 mM dithiothreitol (DTT), 0.5 mM S-adenosylmethionine 
(SAM), 15 mM DL-homocysteine, 14 mM β-mercaptoethanol, 1 mM 
methyltetrahydrofolate with 2.5 μCi of 5-[14C]methyl-tetrahydrofolic acid, and 175 mM 
potassium phosphate buffer, pH 7.5), capped with nitrogen and incubated in the dark at 
37°C for 30 min. The reaction was stopped with 400 μL cold deionized water and stored 
on ice. The product, 
14
C-methionine, was separated from the reactant, 5-[
14
C]methyl-
tetrahydrofolic acid, by ion-exchange column (AG 1-X8 resin, 200-400 mesh) and 
counted for radioactivity.  
Betaine:homocysteine methyltransferase. BHMT activity was measured with an assay 
described by Garrow [26]. Briefly, liver homogenate (100 μL of 15 mg/mL) was added to 
the assay mixture (5 mM DL-homocysteine, 2 mM betaine with 0.1 μCi of 14C-betaine, 
and 50 mM Tris, pH 7.5) and incubated at 37°C for 20 min; the reaction was stopped with 
2.5 mL of cold deionized water and stored on ice. The samples (2 mL) were then applied 
to columns. The unreacted betaine was washed from a column (Dowex AG1-X4, 200-400 
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mesh, hydroxide form) with deionized water and radiolabeled dimethylglycine and 
methionine were eluted with 3 mL of 1.5 M HCl and counted for radioactivity.  
Methylenetetrahydrofolate reductase. MTHFR activity was measured using the assay 
described by Engbersen et al. [27]. Briefly, liver homogenate (100 μL of 5 mg/mL) was 
added to 400 μL of assay mixture (0.27 M potassium phosphate, 1.72 mM 
Ethylenediaminetetraacetic acid (EDTA), 17.25 mM ascorbic acid, 81 μM flavin adenine 
dinucleotide (FAD), 21 mM menadione, 30 μM 5-[14C]methyl-tetrahydrofolic acid, pH 
6.8) and incubated in the dark at 37°C for 20 min; the reaction was stopped with 100 μL 3 
M potassium acetate, (pH 4.5), 200 μL dimedone (50 μmol dimedone in 200 μL 1:1 
ethanol:water), and 10 μL of 1 M formaldehyde and then immediately placed in 95°C 
water bath for 15 min and cooled on ice for 10 min. After addition of 3 mL of toluene, 
samples were vortexed, centrifuged at low speed and the toluene phase was measured for 
radioactivity. 
Methionine adenosyltransferase. MAT activity was assayed using the method of Duce et 
al. [28]. Briefly, 30 μL of homogenate (20 mg/mL) was added to 200 μL of assay mixture 
(125 mM Tris HCl, 250 mM KCl, 12.5 mM MgCl2, 1.25 mM DTT, and 6.25 mM ATP, 
pH 7.80) and equilibrated at 37°C. Reaction was started by adding 20 μL of 62.5 mM 
14
C-methionine and incubated in the dark at 37°C for 45 min. Reaction was stopped with 
750 μL of cold water and stored on ice. Labeled product was eluted on columns (Biorad 




Cystathionine β-synthase. The CBS assay was performed as described by Taoka et al. 
[29]. Briefly, liver homogenate (150 μL of 15 mg/mL) was combined with 400 μL of 
substrate mixture (0.219 mM L-cystathionine, 62.5 mM DL-homocysteine, 3.125 mM 
DL-propargglycine, 0.38 mM SAM, and 0.625 mM pyridoxal-5-phosphate (PLP) in 
187.5 mM Tris-HCl/3.125 mM EDTA, pH 8.3) and allowed to equilibrate at 37°C. Fifty 
μL of 300 mM 14C-serine (0.1 μCi) was added to start the reaction and after 30 min, the 
reaction was stopped with 300 μL of cold 15% trichloroacetic acid and samples stored on 
ice. After centrifugation at 9000×g for 10 min, 500 μl of the deproteinized sample was 
loaded on a column (AG 50W-X4 resin, 200-400 mesh, hydrogen form) and serine was 
washed out with deionized water, 1 M hydrochloric acid, followed again by deionized 
water. 
14
C-cystathionine, was eluted with 5 mL of 3 M NaOH and radioactivity was 
measured. This assay was light sensitive and all sample tubes were covered in aluminum 
foil. 
Cystathionine γ-lyase. CGL was assayed as described by Stipanuk [30]. Briefly, 20% 
liver homogenate was incubated with 100 mM potassium phosphate buffer, 4.0 mM L-
cystathionine, 0.125 mM pyridoxal 5’-phosphate, 0.32 mM nicotinamide adenine 
dinucleotide (NADH) and 1.5 units of lactate dehydrogenase, pH 7.5. The decrease in 
absorbance at 340 nm was monitored to determine activity. 
Real time RT-PCR analysis of BHMT and CGL gene expression. Total RNA was obtained 
from liver samples by the RNeasy kit (Qiagen, Valencia, CA) and cDNA was synthesized 
using 1µg of total RNA using QuantiTect reverse transcription kit (Qiagen, Valencia, 
CA), including a genomic DNA wipeout step. PCR primers and probes for porcine 
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BHMT (U53421) (forward primer, GTT CGC CAG CTT CAT C; reverse primer, CTC 
CAG CTT GTC CTC A; probe, CTC AGA GCC GGA TCG AAT GTC ATG C), CGL or 
cystathionase (DQ499449) (forward primer, CTG AGA GTT TGG GAG GAT A; reverse 
primer, CTT AGG CAC AGA TGA ATG A; probe, AAG TCT TGC TGA GCT TCC 
GGC A), and ß-actin (DQ845171) (forward primer, CCC AGC ACG ATG AAG A; 
reverse primer, CGA TCC ACA CGG AGT A; probe, TCA AGA TCA TCG CGC CTC 
CAG A) were designed using RealTimeDesign software (Biosearch technologies, 
Novato, CA). Expression of ß-actin was used as an endogenous reference to account for 
differences in sample loading and PCR efficiencies between reactions. Taqman probes for 
ß-actin were labeled with reporter dye FAM on the 5' end and quencher BHQ-1 on the 3' 
end. Taqman probes for BHMT and CGL were labeled with reporter dye PULSAR 650 
on the 3' end and quencher BHQ-2 on the 5' end. Amplification reactions were carried out 
using QuantiTect Multiplex PCR NoRox kit (Qiagen, Valencia, CA) for a 20 µL duplex 
PCR reaction volume. All reactions were performed in triplicate on a LightCycler 1.2 
real-time PCR system (Roche, Laval, QC, Canada). The thermal cycling conditions were 
15 min at 95°C to activate HotStarTaq DNA polymerase, followed by 40 cycles of 96°C 
for 1 min and 55°C for 1 min. A sample of reverse transcriptase reaction without reverse 
transcriptase enzyme, and a sample of PCR reaction mixture without cDNA were used as 
negative controls. Relative gene expression was calculated using a formula outlined by 
M. W. Pfaffl [31]; a PCR efficiency of 2.0 was used for all calculations.  
Cytosine extension assay. Global methylation was estimated using the method of 
Pogribny et al. [32]. This method utilizes Hpa II, a methyl sensitive endonuclease which 
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cuts at the sequence CCGG, if the middle CG is unmethylated, leaving an overhanging 
guanine nucleotide. This guanine is paired with a radiolabeled cytosine using Taq 
polymerase thereby estimating the amount of cleaved CCGG sequences in a DNA 
sample.  Briefly, approximately 2 μg of genomic DNA is digested overnight with a 5-fold 
excess of Hpa II, according to manufacturer’s protocol (NEB, Ipswich, MA). A 2 μg 
sample of genomic DNA in digestion buffer without endonuclease serves as a background 
control. A single nucleotide extension reaction was performed on each digested and 
undigested DNA sample in 25 μL reaction mixture containing 2 μg digested DNA, 2.5 μL 
10 x Native Taq buffer (Invitrogen, Burlington, ON, Canada), 0.75 μL 50 mM MgCl, 0.2 
μL of Native Taq polymerase, 0.2 μL [3H]-Cytidine-5'-triphosphate (CTP) (57.4 Ci/mmol) 
(Moravek Radiochemical, Brea, CA) and incubated at 55°C for 1 h. Ten μL of each 
reaction digest was applied to two separate D-81 ion exchange filters, and each filter was 
washed 3 times in sodium phosphate buffer (pH 7.0). The filters were dried overnight and 
counted for radioactivity; results were expressed as relative [
3
H]-dCTP incorporation 
disintegrations per minute (DPM)/0.5 μg of digested DNA.  
Statistical analyses. All data are shown as mean ± standard deviation (SD) and 
differences were considered significant at P<0.05. Comparisons were made using general 
linear model (Minitab Software version 15.1; Minitab Inc. State College, PA) with each 
runt-large littermate representing a matching pair. Data were analyzed using a model 
containing runt/large, pairing, sex and sex × runt/large interaction; non-significant 
parameters were removed (never runt/large) and the model reduced until the adjusted R-
squared was maximized. Analyses in which sex was a significant covariate for runt/large 
 51 
 
differences are indicated; all other differences were in reduced models in which runt/large 
and pairing were maintained. Linear regressions were performed on data versus body 
weight (GraphPad Prism 5, GraphPad Software Inc.). To determine whether difference in 
pair’s birth weight was related to outcome difference, linear regressions were performed 
on significant outcomes, but no significant associations were found. 
2.4 Results 
Animals. At birth, IUGR piglets (0.665 ± 0.121 kg; range: 0.460 – 0.807 kg) were 62 ± 
12% (range, 45 - 74%) of their respective large littermates (1.091 ± 0.158 kg; range: 
0.929 – 1.332 kg) (P<0.001) and came from litters with 7.0 ± 1.4 piglets (range: 5-9 per 
litter). At necropsy, IUGR pigs had body weights 63 ± 11% of their siblings and had 
proportionately smaller (P<0.01) organs than littermates (liver: 66 ± 14%; kidneys: 62 ± 
9%; colon: 72 ± 12%; small intestine mass 68 ± 15%; small intestine length 80 ± 11%) 
such that when organ measurements were corrected for body weight, no differences were 
observed for any organs between IUGR and littermates (Table 2.1); these data suggest no 
sparing effect for organ development during IUGR. 
Metabolite concentrations. Plasma concentrations of urea and amino acids are displayed 
in Table 2.2. Of the sulfur metabolism amino acids, only plasma cysteine concentrations 
were significantly lower in IUGR versus large piglets (P=0.03). Plasma concentrations of 
histidine, isoleucine, alanine, glutamate and hydroxyproline were significantly higher in 
IUGR piglets (P<0.05); sex was a significant covariate for the plasma concentrations of 
histidine and isoleucine. Liver concentrations of taurine (P=0.01) and homocysteine  
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Table 2.1 Body weight (BWT) and organ measurements in large and runt littermate 
piglets 
  Large Runt 
Body Weight (kg) 1.36 ± 0.21 * 0.85 ± 0.13 
Liver (g)  
(g/kg BWT) 
49.6 ± 9.2 * 
36.4 ± 2.9 
32.1 ± 4.5 
37.9 ± 2.0 
Kidney (g) 
(g/kg BWT) 
10.7 ± 2.4 * 
7.8 ± 0.7 
6.4 ± 0.8 
7.7 ± 1.0 
Colon (g) 
(g/kg BWT) 
19.7 ± 5.5 * 
14.7 ± 4.3 
13.9 ± 2.9 
16.9 ± 5.0 




56.0 ± 11.7 * 
40.9 ± 2.7 
455 ± 51 * 
336 ± 25 
37.2 ± 7.5 
43.6 ± 2.9 
362 ± 40 
429 ± 27 * 
 






Table 2.2 Plasma concentrations of amino acids and urea in large and runt littermate 
piglets 
 Large Runt 
 
Urea, mM 4.79 ± 1.21* 3.42 ± 0.93  
Sulfur Metabolism Amino Acids, μM 
Methionine 16.0 ± 3.5 15.6 ± 3.4 
Homocysteine 29.6 ± 4.7 27.7 ± 5.0 
Cysteine 99.1 ± 14.4 * 86.6 ± 4.2 
Taurine 140 ± 20 127 ± 24 
Serine 373 ± 142 415 ± 87 
Glycine 919 ± 182 842 ± 116 
Indispensable Amino Acids, μM 
Arginine 203 ± 44 238 ± 67 
Histidine 55.5 ± 25.7 92.3 ± 59.9 *a 
Isoleucine 147 ± 39 181 ± 37 *a 
Leucine 218 ± 65 260 ± 83 
Lysine 261 ± 103 333 ± 132 
Phenylalanine 101 ± 12 113 ± 35 
Threonine 169 ± 27 203 ± 38 
Tryptophan 39.6 ± 6.7 34.7 ± 11.7 
Valine 324 ± 47 357 ± 66 
Dispensable Amino Acids, μM 
Alanine 644 ± 103 841 ± 85 * 
Asparagine 107 ± 24 137 ± 53 
Aspartate 38.4 ± 11.8 34.6 ± 6.8 
Citrulline 96.9 ± 36.1 90.8 ± 29.1 
Glutamate 175 ± 52 246 ± 62 * 
Glutamine 403 ± 82 468 ± 181 
Hydroxyproline 115 ± 15 128 ± 15 * 
Ornithine 131 ± 89 122 ± 17 
Proline 827 ± 176 921 ± 262 
Tyrosine 212 ± 38 259 ± 80 
 
Results are mean ± S.D. (n=6 per group). * P<0.05; 
a
 Sex included in the model 
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(P=0.04) were lower but cystathionine concentrations were 35% higher (P=0.001) in 
IUGR piglets (Table 2.3); sex was a significant covariate for hepatic cystathionine and 
homocysteine concentrations. 
Hepatic enzyme activities. Sulfur amino acid enzyme specific activities in piglet livers are 
displayed in Table 2.4. Compared to large littermates, IUGR livers had lower activities of 
the remethylation enzyme BHMT (P=0.012), as well as the transsulfuration enzyme, 
cystathionine γ-lyase (CGL) (P=0.04). BHMT (P=0.07) and CGL (P=0.22) only tended 
to correlate with body weight. Total hepatic enzyme capacities (Table 2.5) were lower in 
IUGR for BHMT (P=0.006) and CGL (P=0.014) versus large piglets. Hepatic 
transglutaminase activity tended to be higher (P=0.078) in IUGR piglets (1.56 ± 0.34 
mU/g liver) compared to large littermates (1.26 ± 0.13 mU/g liver). 
BHMT and CGL gene expression. The expressions of BHMT and CGL were normalized 
to β-actin expression in each sample and normalized to a calibrator sample to allow for 
direct comparison between all piglets, giving expression values in arbitrary units (AU). 
BHMT expression did not differ between IUGR (1.00 ± 0.24 AU) and large piglets (0.99 
± 0.21 AU) (P=0.96). Large piglets had higher CGL expression than IUGR (1.24 ± 0.54 
AU versus 0.85 ± 0.54 AU, respectively) (P=0.01). 
Global DNA methylation in the liver. Global DNA methylation was estimated by 
measuring the DPM/0.5 μg DNA in Hpa II digests. The DNA methylation in IUGR 




Table 2.3  Liver concentrations of free amino acids in large and runt littermate piglets 
 Large Runt 
Sulfur Metabolism Amino Acids, nmol/g 
Methionine 326 ± 84 348 ± 107 
S-adenosyl-methionine 68.4 ± 29.0 79.8 ± 31.7 
S-adenosyl-homocysteine 58.2 ± 20.6 69.2 ± 23.9 
SAM/SAH 1.19 ± 0.36 1.19 ± 0.35 
Homocysteine 739 ± 240 *a 532 ± 264  
Cystathionine 2.69 ± 0.68 3.63 ± 0.29 *a 
Cysteine 2637 ±930 2503 ± 430 
Taurine 8447 ± 1138 * 6475 ± 900 
Serine 2239 ± 292 2228 ± 583 
Glycine 5542 ± 836 5366 ± 1167 
Indispensable Amino Acids, nmol/g 
Arginine 78.5 ± 21.1 70.7 ± 24.1 
Histidine 36.1 ± 11.4 38.1 ± 21.2 
Isoleucine 486 ± 81 535 ± 125 
Leucine 1059 ± 236 1213 ± 199 
Lysine 571 ± 134 482 ± 191 
Phenylalanine 412 ± 90 453 ± 120 
Threonine 757 ± 171 747 ± 215 
Valine 1446 ± 221 1464 ± 218 
Dispensable Amino Acids, nmol/g 
Alanine 3124 ± 659 3222 ± 581 
Aspartate 2628 ± 404 2770 ± 656 
Citrulline 348 ± 94 326 ± 143 
Glutamate 1959 ± 241 2409 ± 719 
Glutamine 455 ± 91 392 ± 164 
Hydroxyproline 242 ± 27 243 ± 37 
Ornithine 591 ± 228 510 ± 228 
Proline 1874 ± 301 1925 ± 368 
Tyrosine 502 ± 166 566 ± 156 
 
Results are mean ± S.D. (n=6 per group). * P<0.05; 
a




Table 2.4  Specific activities (nmol product/min/mg total liver protein) of hepatic 






Methionine synthase  0.29 ± 0.10 0.29 ± 0.08 0.01 
Betaine:homocysteine 
methyltransferase  
0.35 ± 0.06 * 0.25 ± 0.06  0.53 a 
Methylenetetrahydrofolate reductase 0.23 ± 0.02 0.23 ± 0.02 -0.24 
Methionine Transsulfuration  
Methionine adenosyltransferase 0.37 ± 0.15 0.36 ± 0.06 -0.28 
Cystathionine β-synthase 3.81 ± 0.70 3.68 ± 2.08 -0.01 
Cystathionine γ-lyase 5.29 ± 1.53 * 4.23 ± 1.72  0.44 b 
 












Table 2.5  Total hepatic capacities (nmol of product/min/kg body weight) of enzymes of 
large and runt littermate piglets, corrected for body weight 
 Large Runt 
Correlation to 
Body Weight (r) 
Remethylation  
Methionine synthase  2.02 ± 0.72 1.96 ± 0.58  0.05 
Betaine:homocysteine 
methyltransferase  
2.43 ± 0.64 * 1.71 ± 0.46  0.49a 
Methylenetetrahydrofolate reductase 1.57 ± 0.20 1.59 ± 0.16 -0.07 
Methionine Transsulfuration  
Methionine adenosyltransferase 2.49 ± 1.01 2.49 ± 0.51 -0.27 
Cystathionine β-synthase 26.7 ± 6.9 25.4 ± 14.8 0.03 
Cystathionine γ-lyase 36.6 ± 11.3 * 29.2 ± 13.0  0.43b 
 











314 DPM/0.5 μg DNA) (P=0.9) and birth weight did not correlate with global 
methylation (P=0.6). 
2.5 Discussion 
Consistent with epidemiological data, we [16-17] and others [18-19] have demonstrated 
that the IUGR runt pig develops biomarkers for metabolic syndrome early in adulthood, 
compared to higher birth weight littermates. Runts are born to adequately nourished 
mothers as a result of a decrease in fetal nutrient delivery via reduced blood supply [33]. 
This porcine model of IUGR allows for the examination of the consequences of a poor 
intrauterine environment on early postnatal metabolism, while controlling for maternal 
nutrition. The IUGR neonate’s epigenetic profile is likely responsible for the permanent 
changes in gene expression which translate to higher risk for diseases later in life [14]. 
Because the methyl groups required for DNA methylation are generated by the 
methionine and folate cycles, we hypothesized that as a result of a poor intrauterine 
environment (i.e. runts), the activities of the key enzymes in these cycles are altered.  
Indeed, this study demonstrated that sulfur amino acid metabolism in IUGR pigs differed 
from their large littermates. Specific activities of enzymes controlling the disposal of 
homocysteine, namely BHMT and CGL, were significantly lower in IUGR piglets. 
Moreover, the overall capacity of BHMT and CGL per kg of body weight was also 
significantly lower in IUGR than large piglets, despite the significantly lower body 
weight in IUGR piglets. Taken as a whole, the double bottleneck of reduced capacity to 
remethylate and transsulfurate homocysteine in IUGR piglets could potentially limit flux 
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through these pathways. If IUGR neonates have a reduced ability to cope with excess 
sulfur amino acids, as suggested by this study in IUGR piglets, then protein-rich diets 
could perturb transmethylation reactions; moreover, diets based on casein, which is rich 
in methionine (2.70%) and poor in cysteine (0.41%) [34], could be particularly 
worrisome. 
BHMT is involved in the removal of homocysteine via the remethylation pathway (Figure 
2.1) [35]. Remethylation allows methionine to be regenerated from homocysteine by 
using methyl groups from serine via the folate cycle (via MS) or by using methyl groups 
from betaine (via BHMT). MS is considered the main enzyme involved in the 
remethylation process, whereas BHMT has been considered to be the minor pathway 
[35]. However, BHMT activity is known to increase to compensate for decreased MS 
activity as a result of folate deficiency [36]. The converse is also true [36]; even though 
we did not observe a higher MS capacity in IUGR pigs, it is possible that flux via MS was 
increased in IUGR piglets to compensate for lower BHMT capacity. Moreover, because 
decreased choline and betaine intakes are associated with higher risk for neural tube 
defects, independent of folate intakes [37,38], the role of BHMT in overall methylation 
status has likely been underestimated. 
When remethylation is limited, transsulfuration increases to accommodate the flux from 
transmethylation; otherwise, homocysteine concentrations escalate [35]. CBS and CGL 
are involved in the catabolism of homocysteine to cysteine in a two-step process (Figure 
2.1); homocysteine is first condensed with serine by CBS to form cystathionine, and then 
cystathionine is catabolized to cysteine and α-ketobutyrate by CGL, also known as 
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cystathionase [35]. CBS activity did not differ between IUGR and large piglets. However, 
because CGL activity was significantly lower in IUGR than large piglet livers, the ability 
of IUGR piglets to clear cystathionine and synthesize cysteine and taurine was reduced. 
Indeed, IUGR piglets in our study had lower concentrations of plasma total cysteine and 
hepatic taurine with an apparent accumulation in hepatic cystathionine. It has previously 
been suggested that CGL is rate-limiting for cysteine and taurine synthesis and its lower 
activity in neonates (particularly premature neonates) has led to the hypothesis that 
cysteine may be conditionally essential in early life because methionine cannot be 
transsulfurated adequately [10,11]. Our data support this clinical observation and suggest 
that IUGR further limits the activity of this enzyme, thereby limiting the IUGR neonate’s 
capacity to remove cystathionine and synthesize cysteine and taurine. This limited 
capacity again questions the use of casein as a protein source in neonates; because casein 
is rich in methionine and poor in cysteine, the conversion of methionine to cysteine is 
critical to maintaining sulfur amino acid adequacy when casein-based diets are fed. 
Cysteine could become the first limiting amino acid even in the presence of excess 
methionine, if this conversion is limited. 
Because IUGR piglets had lower capacity to both remethylate and transsulfurate 
homocysteine, we expected homocysteine concentrations to be elevated. However, 
homocysteine concentrations were similar in plasma and were actually lower in livers of 
IUGR piglets. The lower hepatic accumulation of homocysteine could be due to sufficient 
MS capacity to deal with any excess homocysteine and/or due to adequate CBS and low 
CGL activities which led to the hepatic accumulation of cystathionine. Alternatively, 
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IUGR pigs likely have a lower methionine flux, as a result of the IUGR pig’s lower 
protein metabolism due to reduced intakes [39]; indeed, a lower protein turnover in IUGR 
pigs is supported by their lower plasma urea concentrations in this study. Moreover, 
hyperhomocysteinemia could have been avoided because these piglets were sow-fed, and 
sow milk contains more appropriate amounts of total protein as well as methionine and 
cysteine (ie methionine to cysteine ratio of 1.40, compared to 0.81 in human milk) [40]. It 
is possible that with high protein feeding or with feeding of casein-based diets 
(methionine to cysteine ratio of 6.60) [34], the reduced BHMT and CGL capacities may 
limit remethylation to methionine and eventually lead to hyperhomocysteinemia. 
To assess the level of regulation of enzyme activity, gene expression of BHMT and CGL 
were analyzed in livers by real-time reverse transcriptase-PCR. CGL activity differences 
between the IUGR and large piglets were due to regulation at the transcriptional level, as 
CGL expression was significantly lower in the IUGR piglet livers. In contrast, liver 
BHMT expression was not significantly different between groups; this would suggest that 
the differences in BHMT activity between IUGR and large piglets may be due to some 
type of post-transcriptional mechanism. One such possible mechanism for the down-
regulation of BHMT activity in IUGR pigs could be related to liver transglutaminases, 
which have been shown to intra- and inter-molecularly cross link BHMT subunits and 
thereby reduce BHMT activity in vitro [41]. Indeed, IUGR piglets in this study tended to 
have higher transglutaminase activity (P=0.078). Post-transcriptional mechanisms of 
regulation may be more transient than regulation at an expression level and may be 
related to the availability of substrate. This type of regulation in BHMT activity would be 
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congruent with the very high levels of BHMT found in the liver and could be related to 
BHMT’s role in maintaining remethylation flux in response to MS activity and folate 
deficiency [35,36].  
Because we have recently found that IUGR Yucatan miniature piglets develop early 
biomarkers for chronic diseases in adulthood [16,17], ultimately we were interested in 
whether changes in sulfur amino acid metabolism in IUGR piglets would translate into 
changes in DNA methylation, possibly explaining the higher risk for developing diseases 
later in life. Because dietary methyl group donor (folate, vitamin B12, choline, and 
methionine) supplementation can permanently alter epigenetically determined phenotypes 
[42,43], sulfur amino acid metabolism pathways must be involved in this programming. 
However, we did not observe any changes in hepatic global DNA methylation or in 
concentrations of SAM, SAH or its ratio. SAM/SAH ratio has been called the 
‘methylation index’ and is sometimes considered a reflection of methyl group availability 
[44]. However, it should be noted that global methylation status, which can affect overall 
chromosomal stability and may contribute to the development of cancer [13], should be 
differentiated from promoter-specific methylation, which can modify expression of 
specific genes and is more likely to be the mechanism involved in programming of risk 
for adult diseases [13, 14]. So, although we did not observe any changes in global 
methylation status, it is still possible that promoter-specific changes occurred. Once we 




Reduced prenatal growth in Yucatan miniature piglets impairs their remethylation 
capacity as well as their ability to remove cystathionine and synthesize cysteine and 
taurine, which could have important implications on long term health outcomes. This 
research has immediate implications in the design of postnatal nutritional therapies for 
IUGR infants. For example, the strategy of feeding protein-rich (and especially casein-
rich) diets to infants in order to stimulate growth may need to be re-evaluated. 
Furthermore, it is hoped that this research will contribute to the body of knowledge aimed 
at preventative measures that will help decrease the incidence of the implicated chronic 
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3.1  Abstract  
Methionine is the main source of methyl groups that are
 
partitioned to synthesize various 
methylated products including
 
creatine, phosphatidylcholine (PC) and methylated DNA. 
Whether increased methylation of one product can divert methionine from protein 
synthesis or other methylation products was the aim of this experiment. We used an 
excess of guanidinoacetate (GAA) to synthesize creatine to create a higher demand for
 
available methyl groups in normal weight (NW) (n = 10) and intrauterine growth-
restricted (IUGR) (n = 10) piglets. Anesthetized piglets (15–18 d old) were intraportally 
infused with either GAA or saline
 





infused at 1 h and hepatic metabolites were analyzed for methyl-
3
H 
incorporation 1 h later. Overall, 50-75% of label was recovered in creatine and PC with 
negligible amounts in DNA. In both NW and IUGR piglets, excess
 
GAA led to a 72-
125%
 
increase in methyl incorporation into creatine (P < 0.05) with a concomitant 
decrease by 76-86% in methyl incorporation into PC (P < 0.05) as well as a 38-41% 
decrease in methyl incorporation into protein (P < 0.05), suggesting methyl groups were 
limited for PC synthesis and that methionine was diverted from protein synthesis. 
Compared to NW, IUGR piglets had lower methyl incorporation into PC (P < 0.05), but 
not DNA or protein, suggesting IUGR affects methyl metabolism and could potentially 
impact lipid metabolism. The partitioning of methionine is sensitive to methyl supply in 




3.2  Introduction 
Methionine is an indispensable amino acid that can be utilized either for protein synthesis 
or as a methyl group donor for transmethylation reactions. In order to provide a methyl 
group, methionine is first adenylated to form S-adenosylmethionine (SAM)
 
which is 
partitioned among an estimated 50 methyltransferases, including guanidinoacetate 
methyltransferase (GAMT), phosphatidylethanolamine N-methyltransferase (PEMT) and 
DNA methyltransferase (DNMT) (1).   
Two of the most quantitatively important methylation reactions are the synthesis of 
phosphatidylcholine (PC) from phosphatidylethanolamine (PE) via PEMT and the 
synthesis of creatine from guanidinoacetate (GAA) via GAMT. Creatine can be 
consumed in the diet while the remainder of the whole body requirement needs to be 
endogenously synthesized. Suckling neonates only consume 25% of their requirement 
from milk and thus need to synthesize the remaining 75% (2). Moreover, if dietary 
choline is insufficient to meet PC synthesis requirements, then a growing neonate must 
rely on methylation of PE to meet its PC needs. As these two reactions utilize the 
majority of available methyl groups (3), it is important to understand how demand for 
methyl groups by these two pathways can impact partitioning of methyl supply for all 
methyltransferases, including DNMT.  
DNMT transfers a methyl group to cytosine residues in CpG dinucleotide sequences, 
which, especially when found in a promoter region, can regulate gene expression (4). 
These methylation patterns are initially established during early development but have 
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been shown to be susceptible to postnatal epigenetic modification in response to 
environmental changes (5). Epigenetic modifications have been implicated in the 
developmental origins of adult diseases hypothesis, which describes how an insult to the 
developing fetus or neonate can result in a higher susceptibility to chronic diseases in 
later life. This hypothesis was originally based on epidemiological studies which 
demonstrated an association between low birth weight (i.e., IUGR neonates) and disease 
in later life (6). Since then, it has been well established that nutritional insults early in life 
can ‘program’ an organism’s metabolism, leading to adult diseases (7). Moreover, it has 
been demonstrated that DNA methylation patterns are sensitive to changes in dietary 
methyl supply (8) and IUGR piglets have decreased levels of DNMT-1 mRNA compared 
to normal birth weight piglets (9). As many other methylation reactions compete for these 
methyl groups, it is important to understand how the methyl groups are partitioned 
amongst the various methyltransferase reactions when supply is limited and how this 
partitioning changes in IUGR neonates. 
In order to study the effects of limited methyl supply on transmethylation partitioning, we 
increased the demand for methyl groups required to synthesize creatine. Creatine is 
synthesized via two reactions by the enzymes arginine:glycine amidinotransferase 
(AGAT) and GAMT. AGAT forms GAA and ornithine in the kidney by transferring the 
amidino group from arginine to glycine. GAA is then transported to the liver and 
methylated via SAM to produce creatine and S-adenosyl-L-homocysteine (SAH). The 
regulation of creatine synthesis is by AGAT, due to the feedback inhibitory effect of 
creatine on this enzyme. In contrast, creatine synthesis from GAA via GAMT has been 
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shown in rats to be proportional to GAA availability (10). This suggests that an excess of 
GAA in the liver would drive creatine synthesis and thus potentially increase the demand 
for available methyl groups. Because certain infant formulas (i.e., soy-based) are void of 
creatine, some neonates must rely solely on endogenous synthesis for their entire creatine 
requirement, potentially impacting the available methyl supply. Because neonatal piglets 
consume ~25% of their creatine needs via sow milk (2), we developed an acute model in 
which the piglet must synthesize this additional creatine by infusing an equimolar amount 
of GAA. By creating a high demand for methyl groups, it is possible to determine the 
impact on other methylation reactions that also compete for the remaining methyl groups. 
As fetal undernutrition has been shown to have a lasting impact on offspring, the IUGR 
‘runt’ piglet has been established as a model to study early programming of adult diseases 
(11-14).  Moreover, although we found no difference in the remethylation of 
homocysteine to methionine via MS, we have demonstrated that IUGR piglets have 
limited capacity to remethylate homocysteine to methionine via betaine:homocysteine 
methyltransferase (BHMT), which could have consequences on the availability of methyl 
groups for transmethylation reactions (15). The first objective of this study was to 
determine whether methyl groups can become limiting in the neonate and to determine 
the change in partitioning of methionine and methyl groups during high methyl demand 
(HMD). The second objective was to determine if the partitioning of methyl groups under 






3.3  Materials and Methods  
Reagents. L-[Methyl-
3
H]methionine was obtained from American Radiolabeled 
Chemicals, Inc. (St. Louis, MO). All other chemicals were of analytical grade and were 
from Sigma (St. Louis, MO) or Fisher Scientific (Fair Lawn, NJ). 
Animals. All animal handling procedures were approved by the Institutional Animal Care 
Committee in accordance with the guidelines of the Canadian Council on Animal Care. 
IUGR (n = 10) and normal weight (NW) (n = 10) suckling Yucatan miniature piglets (15-
18 d old) were obtained from Memorial University of Newfoundland breeding colony. 
Anesthesia was induced with an intramuscular injection of ketamine hydrochloride (20 
mg/kg) and acepromazine (0.5 mg/kg) and maintained with isoflurane (1-2%) in oxygen 
(1.5 L/min). A catheter was inserted in the jugular vein and blood was sampled before 
and every 7-15 min after the bolus infusion. After laparotomy using cautery, the portal 
vein was isolated and catheterized for infusions to ensure hepatic exposure to GAA and 
tracer was consistent among pigs and not influenced by extraction from extra-hepatic 
tissues, which might be different in IUGR. The abdominal cavity was then irrigated with 
warm saline, closed and kept warm with a heat lamp. A 2-h constant portal venous 
infusion of either 15 mg ∙ kg-1 ∙ h-1 GAA (HMD groups) or saline (equivalent volume of 
20 mL/h) (Control groups) was initiated and after 1 h, a 11.1 MBq (300 µCi) per kg body 
weight bolus of L-[methyl-
3
H]methionine was infused into the portal vein. An infusion of 
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15 mg ∙ kg-1 ∙ h-1 of GAA for 2 h provides one-third of the GAA required to synthesize a 
piglet’s total daily creatine requirement (2). Sixty min after the bolus infusion, the 
abdomen was reopened and cautery was used to excise a sample of liver which was 
quickly freeze-clamped in liquid nitrogen. Samples of other tissues (i.e., small intestinal 
mid-jejunum, gastrocnemius muscle and brain) were then removed and freeze clamped. A 
labelling period of 60 min following the bolus of L-[methyl-
3
H]methionine was chosen to 
permit sufficient incorporation in various products; in a pilot experiment, serial sampling 
of liver at 30, 45 and 60 min revealed that incorporation of label in DNA and PC 
increased linearly to 60 min while incorporation into creatine was constant (data not 
shown).  This suggests creatine may be leaving the liver at a faster rate than PC.  
Plasma and liver amino acid analyses. Serial plasma samples were analyzed for 
methionine specific radioactivity (SRA); all other plasma and liver amino acid analyses 
were determined on samples taken 1 hour following infusion of L-[methyl-
3
H]methionine. Plasma creatine and GAA concentrations were determined by HPLC 
following derivatization with ninhydrin (16). SAM and SAH concentrations were 
determined by HPLC (17). Methionine concentration was determined by HPLC using 
phenylisothiocyanate derivatization (18). Plasma samples were first deproteinized with 
0.5% trifluoroacetic acid in methanol. Liver samples were homogenized in perchloric 
acid; the supernatant was used to determine free methionine and SAM and the protein 
pellet was hydrolyzed in 6 M HCl for 24 h and used to determine tissue-bound 
methionine. SRA of methionine and SAM (DPM/µmol) was determined by fraction 
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collecting the respective peak and DPM were determined by scintillation counting (Perkin 
Elmer Canada Ltd, Woodbridge, ON, Canada).  
Hepatic analyses of methylated products. Creatine SRA was determined using a modified 
method by Lamarre et al. (19). Tissue was homogenized in a 50 mM Tris buffer (pH 7.4) 
and homogenates were deproteinized with trifluoroacetic acid. Creatine was separated 
with an isocratic mobile phase of 0.1% trifluoroacetic acid and 3% methanol and the 
creatine fraction collected to determine SRA as above.  
For PC analyses, lipids were extracted from liver homogenates using the Folch method 
(20). Lipids were separated via thin layer chromatography using a silica G-60 thin-layer 
chromatography (TLC) plate and a solvent system of chloroform:methanol:acetic 
acid:water (25:15:4:2) followed by iodine visualization. Total phosphorus was determined 
using a modified Bartlett method (21). Perchloric acid was added to each sample which 
was then heated at 180
o
C for 2 h. A 5% ammonium molybdate solution and a Fisk and 
SubbaRow reagent (1-amino-2-naphthol-4-sulfonic acid, sodium metabisulfite and 
sodium sulfite) were added to each tube which were then placed in a boiling water bath 
for 12 min. Absorbance was read at 815 nm for quantification of phosphorus. A portion 
of the sample was used for scintillation counting and data were expressed as SRA 
(DPM/µmol). 
To extract DNA, tissues were homogenized in 50 mM Tris (pH 8), 1% Sodium dodecyl 
sulfate 100 mM EDTA and 100 mM NaCl. Proteinase K was then added (to final 
concentration of 0.8 g/L) and samples were incubated overnight at 56
o
C, followed by 
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phenol extraction. DNA was precipitated with isopropanol and sodium acetate followed 
by resuspension of DNA in 10 mM Tris buffer (pH 8) with 0.1 mM EDTA. DNA 
concentration was determined using a NanoDrop spectrophotometer (Thermo Scientific, 
Wilmington, DE) and DPM were determined with liquid scintillation counting to 
calculate SRA (DPM/µg). 
Calculations. Rate of 
3
H-methyl incorporation into methylated products and liver protein 
was calculated as: 
Rate of 
3
H-methyl incorporation product = (SRAproduct /SRAprecursor) / time × 100,  
 where the precursor was hepatic SAM for methylated products (i.e. creatine, PC, DNA) 
and hepatic free methionine for protein.  
Statistical analyses. Data are presented as means ± SD. Groups were compared using 
two-way analysis of variance (ANOVA) with methyl demand and IUGR as main factors 
with Bonferroni post-tests when main effects were identified by the two-way ANOVA 
(GraphPad Prism 4.0 for Windows, GraphPad Software, San Diego, CA). P values for 
main factors and interaction effects are presented in tables and differences were 
considered significant at P < 0.05.  
3.4  Results 
Metabolite concentrations. A typical mono-exponential decay curve for methionine SRA 
over time is shown in Figure 3.1. In terminal plasma, GAA concentration increased in the 







Figure 3.1  Typical mono-exponential decay curve for methionine SRA over time in a 
pig infused with a 11.1 MBq (300 µCi) per kg body weight bolus of L-[methyl-
3











higher arginine (P = 0.006) and methionine concentrations (P = 0.019) (Table 3.1). In the 
liver, methionine concentration was unchanged but arginine concentration was higher in 
HMD pigs (P < 0.02) (Table 3.2). HMD treatment led to lower hepatic SAM (P < 0.0001) 
and higher hepatic SAH (P = 0.011) concentrations (Table 3.2). As a result, SAM/SAH 
ratio was lower in both HMD groups (P = 0.0002).   
Rate of 
3
H-methyl incorporation into products. The 
3
H-methyl incorporation rate into 
hepatic creatine doubled with GAA infusion in the HMD groups (P = 0.0001), regardless 
of BW (Table 3.3). In contrast, the 
3
H-methyl incorporation rate into hepatic PC was 
lower in both HMD groups (P < 0.0001) (Table 3.3). Moreover, there was also a 
significant interaction effect with BW so that within the control infusion groups, IUGR 
pigs had lower 
3
H-methyl incorporation into PC than NW pigs (P < 0.05), whereas 
3
H-
methyl incorporation into PC was similar between IUGR and NW pigs with HMD 
treatment (Table 3.3). The 
3
H-methyl incorporation rate into protein was lower with 
HMD in both NW and IUGR piglets compared to controls (P = 0.02) (Table 3.3). There 
was no effect of HMD or birth weight on the 
3
H-methyl incorporation rate into DNA 
(Table 3.3).  
Tissue creatine concentrations and specific radioactivity. HMD treatment led to 72-125% 
higher hepatic creatine concentrations in both IUGR and NW groups (P = 0.0006), but 
did not affect creatine concentrations in the muscle, small intestine or brain (Table3. 4). 
However, IUGR pigs had lower creatine concentrations in the small intestine, regardless 
of methyl status (main effect P = 0.014). Creatine SRA (corrected for time) of both 
muscle (P = 0.029) and liver (P < 0.0001) were higher in HMD piglets with no  
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Table 3.1  Plasma concentrations of metabolites in intrauterine growth-restricted (IUGR) 

















 µM  P value 
Methionine 39 ± 9a 38 ± 11a 63 ± 24b 82 ± 47b  0.019 ns ns 
Arginine 134 ± 11 160 ± 47 207 ± 61 221 ± 59  0.006 ns ns 
Creatine 235 ± 43 308 ± 94 284 ± 91 283 ± 33  ns ns ns 
Guanidinoacetate 4.2 ± 1.1a 91.4 ± 37.0b 3.6 ± 1.2a 121 ± 50b  ns 0.0001 ns 
 
1
Data are given as means ± SD; n = 5. BW, birth weight; Tr, treatment. Groups were 
compared using two-way ANOVA with methyl demand (Tr) and BW (IUGR versus NW) 
as main factors with Bonferroni post-tests. P values for main factors and interaction 
effects are presented in last three columns and means with different superscripts are 






Table 3.2 Hepatic concentrations of metabolites in intrauterine growth-restricted (IUGR) 
















 nmol/g wet weight  P value 
Methionine 218 ± 84  243 ± 80 167 ± 67 205 ± 42 ns ns ns 
Arginine 106 ± 42 143 ± 58 101 ± 45 172 ± 32 ns 0.02 ns 
SAM 57.4 ± 8.3b 33.7 ± 6.5a 61.1 ± 11.0b 43.6 ± 7.8a ns 0.0001 ns 
SAH 33.2 ± 5.3a 49.2 ± 12.0b 38.1 ± 11.0ab 48.5 ± 12.0ab ns 0.01 ns 
SAM/SAH  1.78 ± 0.44b 0.74 ± 0.30a 1.70 ± 0.54b 0.93 ± 0.26a ns 0.0002 ns 
 
1
Data are given as means ± SD; n = 5 except IUGR HMD, n = 4.  BW, birth weight SAM, 
S-adenosylmethionine; SAH, S-adenosylhomocysteine; Tr, treatment. Groups were 
compared using two-way ANOVA with methyl demand (Tr) and BW (IUGR versus NW) 
as main factors with Bonferroni post-tests. P values for main factors and interaction 
effects are presented in last three columns and means with different superscripts are 




 Table 3.3 Rate of 
3
H-methyl incorporation into transmethylation products and protein 
(corrected for precursor and time) and metabolite SRA data
1
 in intrauterine growth-

















 Rate of 3H-methyl incorporation   P value 
 Creatine 42.9 ± 7.5a   74.0 ± 19b 38.3 ± 17.5a 85.4 ± 20b  ns 0.0001 ns 
 PC 4.04 ± 1.1c 0.57 ± 0.42a 2.08 ± 1.2b 0.50 ± 0.12a  0.03 0.0001 0.04 
 DNA 271 ± 79 220 ± 130 158 ± 100 178 ± 85  0.12 ns ns 
 Protein 13.0 ± 6.6  8.1 ± 1.0  17.2 ± 6.3 10.4 ± 4.0  ns 0.03 ns 
                                                                SRA                                     P value 
 Creatine  226 ± 36a 444 ± 71b 245 ± 111a 450 ± 100b  ns <0.0001 ns 
 PC  21.1 ± 4.5c 3.1  ± 1.4a 12.8 ± 6.6b 2.9 ± 0.7a  0.04 <0.0001 0.05 
 DNA   1.42 ± 0.39 1.26 ± 0.45 0.94 ± 0.48 0.95 ± 0.43  0.07 ns ns 
 Bound  
Methionine  
22.3 ± 17.0 16.5 ± 12.1 33.0 ± 24.0 25.0 ± 17.1  ns ns ns 
 SAM  513 ± 82 605 ± 120 677 ± 180 525 ± 210  ns ns 0.04 
 Free 
Methionine  




H-methyl incorporation = (SRAproduct / SRAprecursor) / hours × 100,  




Precursor was hepatic SAM for methylated products (i.e. creatine, PC, DNA) and hepatic 
free methionine for protein. 
3
Data are given as means ± SD; n = 5 except IUGR HMD, n = 4. BW, birth weight; PC, 
phosphatidylcholine; SAM, S-adenosylmethionine; Tr, treatment. Groups were compared 
using two-way ANOVA with methyl demand (Tr) and BW (IUGR versus NW) as main 
factors with Bonferroni post-tests. P values for main factors and interaction effects are 
presented in last three columns and means with different superscripts are significantly 





Table 3.4 Tissue creatine concentration and specific radioactivity (SRA) (corrected for 
time)
1
 in intrauterine growth-restricted (IUGR) and normal weight (NW) piglets under 
















 µmol/g wet weight  P value 
Liver  0.56 ± 0.26a 0.96 ± 0.23b 0.48 ± 0.10a 0.83 ± 0.03b  ns 0.0006 ns 
Muscle  5.15 ± 1.40 4.98 ± 1.16 6.09 ± 2.07 6.10 ± 1.16  ns ns ns 
Small 
intestine  
1.28 ± 0.43 1.46 ± 0.20 0.93 ± 0.25 1.09 ± 0.27  0.01 ns ns 
Brain  1.93 ± 0.17 1.97 ± 0.37 2.08 ± 0.78 1.93 ± 0.09  ns ns ns 
 SRA/min        P value 
Liver   3630 ± 660a  7220 ±1400b 4090 ± 800a 7510 ± 700b  ns <0.0001 ns 
Muscle  22.1 ± 6.3 48.9 ± 23.6  34.2 ± 17.3 57.9 ± 36.5  ns 0.029 ns 
Small 
intestine  
627 ± 312  711 ± 205 653 ± 174 746 ± 333  ns ns ns 
Brain  57.5 ± 10.4 68.5 ± 20.3 60.9 ± 28.8 116 ± 72.0  ns ns ns 
1
SRA/min = (DPM/µmol/min). 
2
Data are given as means ± SD; n = 5. BW, birth weight; Tr, treatment. Groups were 
compared using two-way ANOVA with methyl demand (Tr) and BW (IUGR versus NW) 
as main factors with Bonferroni post-tests. P values for main factors and interaction 
effects are presented in last three columns and means with different superscripts are 




differences among groups in the intestine or brain (although creatine SRA in the brain 
tended to be higher during HMD, P = 0.08). Interestingly, the creatine SRA was 9- to 17-
fold higher in the small intestine than in the brain or muscle. 
Partitioning of methyl groups among methylation reactions. To estimate the fractional 
recovery of methyl groups partitioned to each product (i.e., creatine, PC, DNA and 
protein) (Table 3.5), we first determined the DPMproduct/g liver by multiplying the hepatic 
product concentration by the raw uncorrected SRA values found in Table 3.3, which was 
then divided by the sum of the DPMproduct/g liver for all 4 products and multiplied by 
100%. The hepatic product concentrations were pooled estimates across treatments for 
DNA (500 µg/g), PC (16 µmol/g) and methionine (10 µmol/g); because hepatic creatine 
concentrations were different among treatments, treatment means from Table3.4 were 
used for creatine. 
3.5  Discussion 
The objective of this study was to determine the partitioning of methyl groups in a 
situation of high methyl demand by increasing the synthesis of creatine; the methylation 
of GAA to form creatine is quantitatively the most important consumer of methyl groups 
(3). Because creatine synthesis depends on GAA availability with no apparent feedback 
regulation, we infused one-third of the GAA required to synthesize a piglet’s total daily 
creatine requirement (2) in order to acutely consume a large amount of hepatic methyl 
groups and create a situation of HMD. Indeed, the infusion of GAA into the piglet liver  
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Table 3.5 Percent of 
3
H-methyl-labelled product remaining in the liver 60 min after 
infusion with of L-[methyl-
3
H]methionine in intrauterine growth-restricted (IUGR) and 
normal weight (NW) piglets under control or high methyl demand (HMD) conditions
1,2
   









Protein 32 26 51 37 
Creatine 18 66 18 56 
PC 49 8 31 7 
DNA 0.10 0.09 0.07 0.07 












% = (DPMProduct / g) / (DPMSum of all products / g) x 100 
2




for only two hours led to both ~70% greater hepatic total creatine concentration and a 
doubling of the methyl incorporation into creatine, regardless of BW. These data suggest 
that even in neonates, methylation of GAA to creatine is not regulated by feedback 
inhibition. An increase in creatine synthesis from GAA requires an increased proportion 
of the available methyl groups; we hypothesized that if the methyl demand is large 
enough, then the remaining methyl group pool will become limiting for other methylation 
reactions.   
 Total body creatine is 70% greater in 11-day-old piglets than at 4 days old, emphasizing 
the importance of creatine in the neonate (2). It has also been determined that only ~25% 
of the creatine accrued between 4 and 11 d of age could be derived from suckled milk, 
which means ~75% was endogenously synthesized. Obviously, endogenous creatine 
synthesis is critical for a growing neonate, so a sufficient methyl supply is imperative; 
indeed, the proportion of methyl supply consumed by creatine increased from 18% to 56-
66% with HMD (Table 3.5). In a growing immature neonate, it is possible that either 
arginine (i.e., precursor for GAA synthesis) or methionine (i.e., source of methyl groups) 
could be limiting creatine synthesis to only 75% of requirement based on total creatine 
accretion, given these amino acids are essential in the neonate. But by providing 
preformed GAA in the current study, we have effectively provided excess arginine (via 
GAA) and isolated methionine (via SAM) as the potentially limiting precursor. Indeed, 
we observed lower hepatic SAM concentration after GAA was infused, suggesting SAM 
abundance was becoming limiting. Moreover, hepatic arginine concentrations actually 
 87 
 
increased with GAA infusion, suggesting that arginine was being spared from creatine 
synthesis after excess GAA was infused.  
Because the other major user of methyl groups is PEMT (3), we expected PC synthesis to 
be most affected by the diminishing methyl supply in the liver. In the rat, it has been 
estimated that 30% of PC synthesis occurs via PEMT, whereas the other 70% is 
synthesized by the Kennedy pathway which uses choline to form PC (22). However, 
PEMT does respond to choline supply and demand (23-26). A change in flux through 
PEMT would impact methionine metabolism because the pathway utilizes 3 methyl 
groups per PC molecule, perhaps more quantitatively important than creatine synthesis. 
We were interested in whether PC synthesis via PEMT is affected by supply of methyl 
groups in the liver. Indeed, the increased methyl demand created by higher creatine 
synthesis resulted in lower methyl incorporation rate into PC such that the proportion of 
methyl supply consumed by PC decreased from 49% to 8% in the measured products in 
NW piglets (Table 3.5). There are two possible explanations for this result: 1) the drive 
towards greater creatine synthesis could be utilizing a significant portion of available 
methyl groups and thus creating a deficit in methyl supply for this methylation reaction; 
or alternatively, 2) the increased creatine production could result in a higher liver 
concentration of SAH, which is a competitive inhibitor of the PEMT pathway (27). In 
rats, a change in SAM/SAH ratio from 5.6 to 0.6 lowered incorporation of L-[methyl-
14
C]methionine into PC by 75% (27), due to an increase in SAH concentration from 8 to 
2050 nmol/g. Similar to studies in rats (28), GAA supplementation in our piglets led to a 
reduction in hepatic SAM concentration and a modest rise in hepatic SAH concentration 
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(from ~35 to ~49 nmol/g), with a ~50% reduction in SAM/SAH ratio (Table 3.2). It is 
possible that the 85% lower PC incorporation of 
3
H-methyl (in NW piglets) was partially 
due to more SAH competing with SAM for PEMT, but given the dramatically higher 
SAH concentrations necessary to evoke this response in rats (27), it is unlikely that 
competitive inhibition was a major factor in our results. Therefore, we postulate that the 
lower conversion rate via PEMT is likely due to a rapidly limiting methyl supply as a 
consequence of increased creatine synthesis.   
In addition to its role in transmethylation reactions, methionine is also in great demand 
for protein synthesis, especially in the growing neonate. Because methionine is an 
essential amino acid that is first limiting in many dietary proteins, we hypothesized that a 
neonate would be particularly sensitive to a significant re-partitioning of methionine flux 
to methylation reactions. Indeed, in this study, when methionine was diverted to meet the 
high methyl demands for creatine synthesis during GAA infusion, ~40% less methionine 
was incorporated into protein, in the absence of changes in hepatic methionine 
concentration or SRA. This could be due to either a decrease in protein synthesis 
independent of available methionine supply or, more likely, diversion of the methionine 
pool away from protein synthesis to meet the high methyl demand for creatine synthesis. 
This result is particularly profound as it suggests that an increase in methylation demand 
can limit growth in a neonate. Neonatal piglets appear to have a lower fraction of 
methionine diverted to protein synthesis and a higher requirement for methionine flux 
through transmethylation compared to 1-month-old piglets (29). Considering up to two-
thirds of methyl from methionine was recovered in PC and creatine alone (Table 3.5), it is 
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possible that transmethylation reactions are prioritized over protein synthesis in NW 
neonates. This delicate balance of multiple demands for limited methionine demonstrates 
that nutrients involved in transmethylation reactions (i.e., creatine, PC), as well as in 
remethylation (i.e., folate, betaine, choline, vitamins B6 and B12), need to be considered 
when determining sulfur amino acid requirements of neonates.  
Because we have shown that IUGR piglets have a reduced capacity to remethylate 
homocysteine to methionine (15), we investigated whether IUGR piglets have lower rates 
of 
3
H-methyl incorporation into transmethylation products. Interestingly, we observed 
that even under control conditions, IUGR resulted in a ~50% lower methyl incorporation 
into PC (Table 3.3), perhaps due to a higher relative choline intake which occurs in IUGR 
to facilitate compensatory growth (11). With high methyl demand, PC synthesis via 
PEMT was reduced to a similarly low level in both NW and IUGR pigs, suggesting a 
minimal level of PE methylation was reached. This is particularly important in a growing 
neonate as PEMT plays a key role in the distribution of long-chain fatty acids, including 
docosahexaenoic acid, from the liver to other tissues (30). Interestingly, half of 
3
H-methyl 
was diverted to protein synthesis in IUGR pigs, compared to only one-third in NW pigs 
(Table 3.5). Although SAM/SAH ratios were not different, it would appear there was a 
lower total transmethylation flux (i.e., to PC and creatine) with IUGR with more 
methionine partitioned to protein synthesis. Although hypomethylation of DNA is 
associated with programming of adult disease (7), which has been demonstrated in IUGR 
piglets by us (11, 12) and others (13, 14), we found no difference in methyl incorporation 
into DNA among groups.  
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In conclusion, an increase in available GAA results in greater methyl incorporation into 
creatine and reduced methionine incorporation into protein. The partitioning of available 
methionine between its primary maintenance role as a methyl donor and its role in growth 
via protein synthesis has important implications when determining amino acid 
recommendations for neonates. For example, the requirement of methionine for creatine 
synthesis will vary dramatically in infants fed creatine-free soy-based formula versus 
those fed bovine milk-based formulas providing up to 36% of creatine needs (31). And 
because of its potential to both spare arginine and increase muscle creatine, GAA is also 
currently being investigated as a supplement to improve performance in animal 
production (32, 33). Moreover, the current study has demonstrated that methyl supply can 
become limiting in the neonate and that this leads to a re-partitioning of methyl groups 
among methylation reactions. Indeed, the increase in methylation of GAA for creatine 
synthesis resulted in a decreased supply of methyl groups which led to dramatically 
reduced methyl incorporation into PC. Furthermore, neonates born with IUGR experience 
lower methylation rates of PC which could potentially have implications for lipid 
metabolism.  
3.6 Acknowledgments 
The authors thank Dr. Simon Lamarre for his technical assistance with HPLC method 
development. L.E.M., J.A.B., and R.F.B. conceived and designed the research; and 
L.E.M. and R.F.B. performed the experiments, analyzed the data, and drafted the 
manuscript. All authors interpreted the results of the experiments, revised the manuscript, 
and read and approved the final manuscript 
 91 
 
3.6  References 
[1] Schubert HL, Blumenthal RM, Cheng X. Many paths to methyltransfer: a chronicle 
of convergence. Trends Biochem Sci. 2003;28:329–35. 
[2] Brosnan JT, Wijekoon EP, Warford-Woolgar L, Trottier NL, Brosnan ME, Brunton 
JA, Bertolo RF. Creatine synthesis is a major metabolic process in neonatal piglets 
and has important implications for amino acid metabolism and methyl balance. J 
Nutr. 2009;139:1292–7. 
[3] Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. Is it time to reevaluate 
methyl balance in humans? Am J Clin Nutr. 2006;83:5–10. 
[4] Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16:6–
21. 
[5] Plagemann A, Harder T, Brunn M, Harder A, Roepke K, Wittrock-Staar M, Ziska T, 
Schellong K, Rodekamp E, Melchior K, et al. Hypothalamic proopiomelanocortin 
promoter methylation becomes altered by early overfeeding: an epigenetic model of 
obesity and the metabolic syndrome. J Physiol. 2009;587:4963–76. 
[6] Godfrey KM, Barker DJ. Fetal nutrition and adult disease. Am J Clin Nutr. 
2000;71:1344S–52S. 
[7] McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: 
prediction, plasticity, and programming. Physiol Rev. 2005;85:571–633. 
[8] Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J, Thurston 
A, Huntley JF, Rees WD, Maloney CA, et al. DNA methylation, insulin resistance, 
and blood pressure in offspring determined by maternal periconceptional B vitamin 
and methionine status. Proc Natl Acad Sci U S A. 2007;104:19351–6.  
[9] Liu JB, Chen DW, Yu B, Mao XB.  Effect of maternal folic acid supplementation on 
hepatic one-carbon unit associated gene expressions in newborn piglets. Mol Biol 
Rep. 2011;38:3849–56. 
[10] da Silva RP, Nissim I, Brosnan ME, Brosnan JT. Creatine synthesis: hepatic 
metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo. Am J 
Physiol Endocrinol Metab. 2009;296:E256–61.  
[11] Myrie SB, McKnight LL, Van Vliet BN, Bertolo RF. Low birth weight is associated 
 92 
 
with reduced nephron number and increased blood pressure in adult Yucatan 
miniature swine. Neonatology. 2011;100:380–6. 
[12] McKnight LL, Myrie SB, MacKay DS, Brunton JA, Bertolo RF. Glucose tolerance is 
affected by visceral adiposity and gender, but not birth weight or early nutrition, in 
Yucatan miniature pigs. Appl Physiol Nutr Metab. 2012;37:106–14. 
[13] Poore KR, Forhead AJ, Gardner DS, Giussani DA, Fowden AL. The effects of birth 
weight on basal cardiovascular function in pigs at 3 months of age. J Physiol. 
2002;539: 969–78. 
[14] Poore KR, Fowden AL. The effects of birth weight and postnatal growth patterns on 
fat depth and plasma leptin concentrations in juvenile and adult pigs. J Physiol. 
2004;558(Pt 1):295–304. 
[15] MacKay DS, Brophy JD, McBreairty LE, McGowan RA, Bertolo RF. Intrauterine 
growth restriction leads to changes in sulfur amino acid metabolism, but not global 
DNA methylation, in Yucatan miniature piglets. J Nutr Biochem. 2012; 23:1121–7. 
[16] Buchberger W, Ferdig M. Improved high-performance liquid chromatographic 
determination of guanidino compounds by precolumn derivatization with ninhydrin 
and fluorescence detection. J Sep Sci. 2004;27:1309–12. 
[17] Ratnam S, Wijekoon EP, Hall B, Garrow TA, Brosnan ME, Brosnan JT. Effects of 
diabetes and insulin on betaine-homocysteine S-methyltransferase expression in rat 
liver. Am J Physiol Endocrinol Metab. 2006;290:E933–9. 
[18] Bidlingmeyer BA, Cohen SA, Tarvin TL. Rapid analysis of amino acids using pre-
column derivatization. J Chromatogr. 1984;336: 93–104.  
[19] Lamarre SG, Edison EE, Wijekoon EP, Brosnan ME, Brosnan JT. Suckling rat pups 
accumulate creatine primarily via de novo synthesis rather than from dam milk. J 
Nutr. 2012;140:1570–3.  
[20] Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and 
purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509. 
[21] Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem. 
1959;234:466–468. 




[23] Schneider WJ, Vance DE. Effect of choline deficiency on the enzymes that 
synthesize phosphatidylcholine and phosphatidylethanolamine in rat liver. Eur J 
Biochem. 1978;85:181–7. 
[24] Cui Z, Vance DE. Expression of phosphatidylethanolamine N-methyltransferase-2 is 
markedly enhanced in long term choline-deficient rats. J Biol Chem 1996;271:2839–
43. 
[25] Jacobs RL, Devlin C, Tabas I, Vance DE. Targeted deletion of hepatic 
CTP:phosphocholine cytidylyltransferase A in mice decreases plasma high density 
and very low density lipoproteins. J Biol Chem. 2004;279:47402–10. 
[26] Jacobs RL, Stead LM, Devlin C, Tabas I, Brosnan ME, Brosnan JT, Vance DE. 
Physiological regulation of phospholipid methylation alters plasma homocysteine in 
mice. J Biol Chem. 2005;280:28299–305 
[27] Hoffman DR, Marion DW, Cornatzer WE, Duerre JA. S-Adenosylmethionine and S-
adenosylhomocysteine metabolism in isolated rat liver. Effects of L-methionine, L-
homocysteine, and adenosine. J Biol Chem. 1980;255:10822–7. 
[28] Setoue M, Ohuchi S, Morita T, Sugiyama K. Hyperhomocysteinemia induced by 
guanidinoacetic acid is effectively suppressed by choline and betaine in rats. Biosci 
Biotechnol Biochem. 2008;72:1696–703. 
[29] Bauchart-Thevret C, Stoll B, Chacko S, Burrin DG. Sulfur amino acid deficiency 
upregulates intestinal methionine cycle activity and suppresses epithelial growth in 
neonatal pigs. Am J Physiol Endocrinol Metab. 2009;296:1239–50. 
[30] Watkins SM, Zhu X, Zeisel SH. Phosphatidylethanolamine-N-methyltransferase 
activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid 
metabolism in mice. J Nutr. 2003;133:3386–91. 
[31] Edison EE, Brosnan ME, Aziz K, Brosnan JT. Creatine and guanidinoacetate content 
of human milk and infant formulas: implications for creatine deficiency syndromes 
and amino acid metabolism. Br J Nutr. 2013;Feb 7:1–4.  
[32] Michiels J, Maertens L, Buyse J, Lemme A, Rademacher M, Dierick NA, De Smet 
S. Supplementation of guanidinoacetic acid to broiler diets: effects on performance, 




[33] Dilger RN, Bryant-Angeloni K, Payne RL, Lemme A, Parsons CM. Dietary 
guanidino acetic acid is an efficacious replacement for arginine for young chicks. 




Chapter 4: Betaine is as effective as folate at re-synthesizing methionine for protein 
synthesis during moderate methionine deficiency in piglets 
Laura E. McBreairty
1
, Jason L. Robinson
1




, Janet A. 
Brunton
1




Chapter 4 was designed by L. McBreairty, J. Robinson and R. Bertolo.  L. McBreairty 
and J. Robinson conducted the animal care and analyzed plasma folate, choline, 
dimethylglycine and betaine as well as plasma phenylalanine enrichment.  Breath samples 
for IRMS were analyzed by S. Harding at King’s College London, London, UK.  All 
other research was conducted by L. McBreairty and L. McBreairty analyzed all data.  The 









Methionine is an essential amino acid that is in high demand in neonates for protein 
synthesis as well as for transmethylation reactions, such as creatine synthesis and DNA 
methylation. Transmethylation reactions produce homocysteine, which can be either 
converted to cysteine or re-methylated to methionine via folate or betaine (synthesized 
from choline).  In the neonatal piglet approximately half of methionine flux is used for 
transmethylation reactions with 45% of homocysteine undergoing re-methylation.  It is 
unclear whether both remethylation pathways are of equal importance in the neonate. The 
objective of this study was to determine whether supplementation with folate, betaine or a 
combination of both (n=6 per treatment) can equally re-synthesize methionine for protein 
synthesis when dietary methionine is limiting.  We measured 
13
C-phenylalanine oxidation 
as an indicator of protein synthesis in piglets adapted for 6 days to a low-methionine diet 
devoid of folate, choline and betaine as well as following 2 days of supplementation.  
Prior to supplementation, piglets had lower levels of plasma folate, betaine and choline 
compared to baseline with no change in homocysteine. Post-supplementation, 
phenylalanine oxidation levels were 20-46% lower with any methyl donor 
supplementation (P = 0.006) with no difference among groups.  Furthermore, both methyl 
donors led to lower levels of homocysteine following supplementation (P < 0.05).  These 






The amino acid methionine is important in the neonate not only for protein synthesis and 
growth, but in addition, it is adenylated to S-adenosylmethionine (SAM), the universal 
methyl donor in over 50 transmethylation reactions (1).  SAM is utilized to expand body 
pools of transmethylation products such as phosphatidylcholine (PC), as well as creatine, 
which increases in the neonatal piglet by ~10% per day  (2).  In addition, SAM provides 
the methyl group used to establish and maintain epigenetic patterns of DNA methylation, 
which can be permanently affected by the neonatal diet (3).  The methionine required for 













 (4).  This high demand for 
transmethylation reactions highlights the importance in understanding how the dietary 
supply of methionine and methyl groups affects availability of methionine for growth in 
the neonate.       
The availability of methionine for its various functions is dependent on dietary 
methionine as well as the remethylation of methionine. During transmethylation, SAM is 
converted to S-adenosylhomocysteine (SAH) which is further hydrolyzed to form 
homocysteine, a non-protein amino acid that can either be irreversibly converted to 
cysteine or remethylated to methionine by receiving a methyl group from 5-
methyltetrahydrofolate or betaine, the oxidation product of choline [5].  5-
Methyltetrahydrofolate provides a methyl group via the ubiquitous enzyme methionine 
synthase (MS) while betaine-homocysteine methyltransferase (BHMT) transfers a methyl 
group from betaine, a reaction that is limited to the liver and kidney [6].  Remethylation 
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via betaine also produces dimethylglycine (DMG), an inhibitor of BHMT [7], which is 
oxidized to sarcosine via DMG dehydrogenase using folate as a cofactor [8].   
In the neonatal piglet, ~50% of methionine is converted to SAM while at 1 month old, 
only 30% of methionine is utilized for transmethylation reactions [9].  Furthermore, the 
fraction of homocysteine remethylated by 5-methyltetrahydrofolate and betaine in the 
neonate is ~45%, whereas only 20% of homocysteine undergoes remethylation at 1 
month.  This shows the significant demand placed on methionine for transmethylation 
reactions during the first weeks of life and demonstrates the importance of the 
remethylation nutrients, folate and betaine, to maintain methionine availability.  Although 
the minimum dietary methionine requirement has been established in the human neonate, 
this value was determined under conditions of excess dietary cysteine [10] which has 
been shown in piglets to spare the methionine requirement by up to 40% [11].  This 
sparing effect emphasizes that the methionine requirement is not static and nutrients 
involved in both methionine demand (i.e. cysteine) and supply (i.e. folate, betaine) should 
be considered when determining the dietary methionine requirement.  
Methionine availability will depend on dietary levels of these methyl-related nutrients.  
For the growing neonate, the concentrations of these nutrients are highly variable among 
infant formulas and breast milk.  Serum free choline is higher in breast fed compared to 
formula fed infants and the choline concentration of breast milk is influenced by maternal 
choline status [12].  Although the average choline concentration in breast milk is ~1200 
nmol/ml, the concentration of betaine is only 7 nmol/ml [13] making choline the primary 
source of betaine in the neonate.  Infant formulas are often derived from cow’s milk 
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which has a higher casein/whey ratio than human breast milk.  Because casein is high in 
methionine while whey is high in cysteine, cow’s milk also has a higher 
methionine/cysteine ratio of ~3 versus ~0.8 found in human milk [14].  Studies 
investigating the relationship between these remethylation nutrients have demonstrated 
that dietary choline deficiency leads to lower hepatic folate [15] while folate deficiency 
results in hepatic depletion of choline [16], further emphasizing the need to assess the 
relationship between nutrients involved in methionine metabolism when considering 
individual nutrient requirements.   
Because of the high demand placed on methionine during early development and the 
variability of methyl donors in the neonatal diet, the objective of this study was to 
determine how important remethylation is to methionine availability. Moreover, we 
wanted to compare the effectiveness of folate, betaine or a combination of both to 
remethylate methionine. In order to elicit a response with remethylation, we employed a 
diet that was moderately deficient in methionine and used the indicator amino acid 
oxidation (IAAO) technique to detect changes in protein synthesis.  The IAAO technique 
is based on the concept that when one amino acid is limiting for protein synthesis, the 
remaining amino acids will be oxidized; by increasing the availability of the limiting 
amino acid (i.e. more methionine from remethylation), the oxidation of other amino acids 
will decrease, reflecting a higher incorporation into protein [17].  Using L-[
13
C]-
phenylalanine as our indicator amino acid, we were able to determine changes in the rate 
of phenylalanine oxidation prior to and following methyl donor supplementation, 
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consequently reflecting the effect of these methyl donors at increasing the availability of 
methionine for protein synthesis.    
4.3 Materials and Methods 
Animal protocol. All animal-handling procedures were approved by the institutional 
animal care committee in accordance with the guidelines of the Canadian Council on 
Animal Care.  Eighteen 5-8 day old Yucatan miniature piglets were obtained from the 
Memorial University of Newfoundland breeding colony.  Upon arrival, general anesthesia 
was induced with isoflurane (1-2%) in oxygen (1.5 L/min) and piglets were implanted 
with two silastic venous catheters (femoral and jugular) for blood sampling and a gastric 
catheter for intragastric (IG) feeding following recovery [18].  Piglets were administered 
antibiotics via both venous catheters (Borgal: 20 mg trimethoprim and 100 mg 
sulfadoxine) (Intervet Canada Ltd, Kirkland, Canada) immediately following surgery and 
daily for the duration of the study.  The analgesic Temgesic (0.03 mg/kg of 
buprenorphine hydrochloride) (Schering-Plough, Whitehouse Station, New Jersey) was 
also administered immediately following surgery as well as every 12 hours post-surgery 
until no guarding was observed by piglets.  Once post-surgical drugs were administered, 
piglets were transferred to individual metabolic cages (1 m x 1 m) equipped with heat 
lamps in a room maintained at 28 
o
C and lit from 0800-2000 hours.  Diet was 
administered using a peristaltic pump attached via a dual port swivel and tether system 
(Lomir Biomedical, Montreal, Quebec, Canada) that allowed for free movement of piglets 
around the cage while allowing for continuous IV or IG infusions.  Blood was sampled 





future analysis.  Piglets were weighed daily and diet infusion rates were adjusted 
accordingly. 
Diet regimen. Immediately following surgery (day 0) piglets were parenterally fed at 50% 
of requirement via the jugular catheter.  On the morning of day 1, diet delivery rate was 
increased to 75% of the requirement and by evening of the same day, diet delivery was 
changed to enteral feeding via the IG catheter at 100% of total requirement.  From day 0 
to day 5 piglets were fed an adaptation diet which provided adequate methionine (0.3 g ∙ 
kg
-1 ∙ day-1) (Figure 4.1) [19] and was devoid of folate.  On day 5, methionine was 
reduced to a moderately deficient level of 0.2 g ∙ kg-1 ∙ day-1 for the remainder of the 10 
day study and alanine was adjusted to maintain an isonitrogenous diet.  On day 7, piglets 
were randomly assigned to receive supplementation with either folate (n=6), betaine 
(n=6) or both folate and betaine (n=6).  Folate was supplemented at a rate of 38 ug ∙ kg-1 ∙ 
day
-1
 providing 200% of the daily folate requirement in a piglet (NRC, 1998) and betaine 
was provided at a rate of 235 mg ∙ kg-1 ∙ day-1.  There is currently no specified 
requirement for betaine in piglets and the dose provided in this study is the molar 
equivalent of the methionine requirement of 0.3 g∙ kg-1 day-1.  Although the molar betaine 
supplementation level used in this study was higher than folate, betaine can only be 
synthesized via choline oxidation and cannot be re-synthesized following transfer of its 
methyl group, while the methyl group provided by folate can be regenerated via serine 
[20].  Both adaptation and test diets provided 16 g ∙ kg-1 ∙ day-1 of protein supplied by 
crystalline amino acids as previously described (Table 4.1) [18].  Non-protein energy was 













Table 4.1 Amino acid composition of elemental diet. 
Amino Acid g AA/kg.d 
Alanine 1.663 
Arginine 0.942 
Aspartic acid 0.942 
Cysteine 0.224 


















soybean oil which was administered into the diet line via a syringe pump at a rate of 0.12 
ml ∙ kg-1 ∙ h-1.  Vitamins (Multi-12K Pediatric, Sabex, Boucherville, Canada) and minerals 
were provided in the diet at >100% of the requirement and diet was administered at a rate 
of 11.3 ml ∙ kg-1 ∙ h-1.  Diet was made under aseptic conditions as previously described 
[18].   
 Isotope Infusion protocol. On days 6 and 9 of the study, piglets were moved to individual 
and sealed Plexiglas boxes (60 x 40 x 40 cm) fitted with a tether and swivel system to 
allow for blood collection via venous catheters, delivery of isotope and continuous 
delivery of diet.  A primed (7 mg/kg), constant (2.4 mg/kg administered every 30 
minutes) infusion of L-[
13
C]-phenylalanine (99%, Cambridge Isotope Laboratories, 
Andover, MA) was given intragastrically via the diet line for 6 hours [21].  Blood was 
sampled every 30 minutes and heparinized plasma was separated and stored at -20 
o
C for 
later analysis of L-[
13
C]-phenylalanine enrichment.  Breath samples were collected and 
the rate of CO2 production was determined via an indirect calorimetry system (Qubit 
systems, Kingston ON, Canada).  A vacuum pump was used to draw air from the boxes at 
a fixed known rate controlled by a 16 series mass flow controller precision gas flow 
controller (Qubit systems, Kingston ON, Canada).  Individual 20 minute breath samples 
were collected using a 4-channel gas switcher to direct flow from a specified box into a 
midget bubbler (Kimble Chase Kontes, TN, USA) containing sodium hydroxide (1 
mol/L).  Following the collection, the sodium hydroxide was quickly poured into an 
empty glass vacutainer and the seal was immediately replaced.  A syringe was used to 
evacuate air from the vacutainer which was then placed in a 4 
o





CO2 enrichment.  Following collection of breath, the channel gas switcher 
was used to direct air towards a Model CD-3A CO2 analyzer (AEI technologies, 
Naperville, Il, USA) to determine the concentration of CO2 in the box and CO2 
production rate via the calorimetry system software (Qubit systems C960 multichannel 
gas exchange system software, Kingston On, Canada).  
Plasma Metabolites. Total homocysteine and cysteine concentrations were determined 
according to [22].  Concentrations of choline and betaine were quantified using an HPLC 
MS/MS as described elsewhere [23,24]. Breifly, plasma samples were mixed with 3 
volumes of acetonitrile containing 100 µM of D11-Betaine and D9-Choline.  The 
supernatant was extracted and injected onto an Atlantis HILIC Silica 3 µM 2.1x100mm 
column and samples were analyzed on a Waters Alliance 2795 HPLC system (Water 
Corporation, Milford, MA, USA) using a Micromass Quattro Ultima tandem mass 
spectrometer (triple-quad) (Water Corporation, Milford, MA, USA). The compounds 
were detected in multiple-reaction monitoring mode using the following m/z transitions: 
D11-Betaine 129→  68, Betaine 118 → 59, D9-Choline 113 → 69, Choline 104 → 60.  
Plasma concentrations were calculated using dialyzed plasma spiked with choline and 
betaine standards, and expressed relative to D11-betaine and D9-choline. Concentrations 
were computed using MassLynx Software (Waters Corporation: Milford, MA).  Plasma 
folate concentrations were determined using folate kit (Abbott, B1P740) and Architect 
Clinical Chemistry Analyzers.   
CO2 enrichment in breath. Breath CO2 was analysed for 
13
C isotope enrichment by 
isotope ratio mass spectrometry - Delta XP isotope ratio mass spectrometer interfaced to a 
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Gas Bench II (Thermo Fisher Scientific, Bremen, Germany).  Briefly, 200 ul of the NaOH 
solution containing the sequestered CO2 was transferred to Exetainers (Labco Limited, 
Lampeter, Wales, UK) and capped.  Using a 27 gauge needle and syringe, 300 ul of 1 
mol/L HCl was added to each exetainer through the air tight septum.  Samples were 
vortexed and allowed to stand at room temperature for 30 minutes before analysis by 
isotope ratio mass spectrometery.  Mean 
13
CO2 enrichment was compared against 
standardized reference gas which was calibrated against Vienna Pee Dee Belemnite.   
Plasma Enrichment of [
13
C] phenylalanine. The plasma enrichment of [
13
C] 
phenylalanine was analyzed using a modified gas chromatography–mass spectrometry 
(GCMS) method of Lamarre [25].  50 µL of plasma was mixed with 135 µL of 133 mM 
pentafluorobenzyl bromide and 25 µL of 0.5 M phosphate buffer (pH 8) in an eppendorf 
tube. Samples were placed into a 60 °C oven for 60 minutes to allow for alkylation of 
phenylalanine by pentafluorobenzyl bromide. 335 µL of hexane was added to terminate 
derivitization. After a second mixing, the organic phase was transferred to a GCMS vial.  
Derivatized samples were analyzed using a GCMS equipped with an autosampler 
(Agilent Technologies). A 2 µL aliquot of the organic phase was injected onto a DM-
5MS column (0.25 mm x 30 m x 0.22 µm). The GC (6890N Network GC System) oven 
was preheated to 50 °C and equipped with helium carrier gas. A temperature of 50 
o
C was 
held for 3 min and was increased to 280 
o
C at a rate of 30 °C/min which was then held for 
4 min. After column separation, 20 eV of collision energy was used to ionize samples 
upon entering a quadrapole MS (5973 inert Mass Selective Detector). Selected-ion 
monitoring mode was used to monitor specific ions for phenylalanine (m/z = 434 and 
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435). Area under the curve for each ion was recorded and used to calculate the ratio of 
[M+1] phenylalanine as compared to [M+0] phenylalanine.  
Calculations. Phenylalanine flux, rate of phenylalanine oxidation and percent 
phenylalanine oxidized were calculated according to equations by Zello [26]; 
Phenylalanine flux (Q): 
Q = i[(Ei/Ep)–1]; 
Where Ei was the enrichment of L-[
13
C]-phenylalanine infused (MPE), Ep was the 
enrichment of plasma L-[
13
C]-phenylalanine above baseline at isotopic plateau (MPE) 
and i was the rate of L-[
13
C]-phenylalanine infused (µmol ∙ kg-1 ∙ h-1). 
 
The rate of phenylalanine oxidation (Pheox): 
Pheox = [(FCO2 x ECO2 x 44.6 x 60) / (W x 0.93 x 100)] x (1/Ep-1/Ei) x 100; 
Where FCO2= CO2 production rate (cm
3
/min) determined by Qubit system software as 
described above, ECO2 = 
13
CO2 enrichment in expired breath at isotopic steady state 
(atom percent excess) determined by isotope ratio mass spectrometry and W was the 
weight (kg) of the piglet. The constants 44.6 pmol/cm
3
 and 60 min/h converted FCO2 to 
micromoles per hour, and the factor 100 changed atom percent excess to a fraction.  0.93 
was used to account for CO2 retention in piglets [27].  
The % dose of L-[
13
C]-phenylalanine oxidized (%Pheox): 




Non-oxidative disposal (NOD) and phenylalanine released from protein (PB) were 
calculated according to House et al. [28] based on the following equation:  
Q = NOD + Pheox = PB + I; 
Where Q = phenylalanine flux as described above, NOD = non-oxidative disposal of 
phenylalanine, Pheox = phenylalanine oxidation, PB = phenylalanine released from 
protein and I = phenylalanine intake.  Using our previously calculated phenylalanine flux 
and oxidation values, we were able to solve for NOD and PB.   
Statistics. Data are presented as means ± SD.  The effect of methyl donor 
supplementation was assessed using a two-way ANOVA to compare groups; the two 
main effects were treatment (ie various methyl donors) and rescue (ie pre- and post-
supplementation).  Differences were considered significant at P < 0.05 (GraphPad Prism 
4.0 for Windows, GraphPad Software, San Diego, CA).                                                                                                                                
4.4 Results 
Piglet weight. Piglet weight was higher post-rescue versus pre-rescue with no differences 























Figure 4.2 Weight of piglets receiving a methyl group deficient diet moderately deficient 
in methionine (Day 7) as well as following supplementation with folate, betaine or a 






Plasma metabolites following methyl deficiency. Because all piglets on day 7 were 
receiving the same diet, these data include all pigs.  As a baseline reference, plasma 
concentrations of folate, betaine and choline were measured in a separate group of 5-8 
day old sow fed piglets (n=14) undergoing the same initial surgery and were compared to 
day 7 piglets from this study. On day 7, plasma folate (16.1 ± 7.8 ng/ml) and choline (6.9 
± 6.8 µM) concentrations were lower than the day 0 reference group (folate: 45.7 ± 22.3 
ng/ml; choline: 23.2 ± 14.1 µM).  In all animals on day 7, plasma betaine concentration 
was below the level of detection of 0.55 µM, compared to the betaine concentration of 
48.7 ± 27.1 µM in the day 0 reference group.  Plasma homocysteine concentration on day 
7 (30.0 ± 14.5 µM) was similar to reference group data (28.8 ± 13.6 µM).    
Plasma metabolites following supplementation. There was a main effect of rescue on 
plasma homocysteine concentration with 12-65% lower levels post-rescue versus pre-
rescue (P = 0.0009) with no treatment x rescue interaction. 
Phenylalanine infusion. There was a main effect of rescue on both the rate of 
phenylalanine oxidation (P = 0.006) and % phenylalanine oxidized (P = 0.004), with 20-
46% lower levels in both measures during the post-rescue infusion, with no treatment x 
rescue interaction. There were no differences in non-oxidative disposal, protein 
breakdown or phenylalanine flux following supplementation (Table 4.2). 
4.5 Discussion 
Methionine metabolism is especially important during early development when higher 
levels of both protein synthesis and transmethylation via SAM create a high demand for  
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Table 4.2  Phenylalanine kinetics following a primed, constant infusion of L-[
13
C]-
phenylalanine in piglets both after 6 days of receiving a methyl group deficient diet 
moderately deficient in methionine and following supplementation with either folate, 
betaine or a combination of both.  
 
 Folate Betaine Folate and Betaine P-Value 
 Pre-rescue Post-rescue Pre-rescue Post-rescue Pre-rescue Post-rescue Rescue 
 % Pheox 1.37± 0.59 0.74± 0.30 1.54± 0.77 0.83± 0.63 1.30± 0.41 1.08± 0.54 0.004 
   umol · kg-1 · h-1   
Pheox  6.38± 2.82 4.35± 1.77 7.70± 3.90 4.56± 3.75 6.85± 2.12 4.79± 2.46 0.006 
NOD 477 ±107 612 ±156 498± 74 573± 111 544 ±110 472± 74 ns 
Pn BD 275± 108 408± 157 297 ±75 370± 111 343± 111 268 ±74 ns 
Flux 483± 108 616 ±157 505± 75 577± 111 550± 111 477 ±74 ns 
Intake  29.05 29.05 29.05 29.05 29.05 29.05 ns 
Data are means ± SD; n = 6 Means with different superscripts are significantly different 
within rows, P < 0.05; ns, not significant.  Pheox, rate of phenylalanine oxidation; % 
Pheox, percentage of phenylalanine dose oxidized; NOD, non-oxidative disposal; Pn BD, 
protein breakdown. Data were analyzed by 2-way ANOVA with main effects of treatment 
(ie various methyl donors) and rescue; only rescue was significant for all outcomes so 







the amino acid which must be partitioned between these two functions.  The objective of 
this study was to determine the importance of remethylation on methionine availability 
and to evaluate the relative effectiveness of the two methyl donor nutrients, folate and 
betaine, in remethylating methionine.  We fed a methyl-deficient diet with a moderately 
deficient level of methionine for 6 days to minimize available methionine making it first 
limiting for protein synthesis.  After 2 days of supplementation with folate, betaine or 
both, we hypothesized that the increased remethylation will increase available methionine 
and stimulate protein synthesis, which was measured by indicator amino acid (ie 
phenylalanine) oxidation.  Supplementation with folate, betaine or a combination of both 
equally lowered the rate of phenylalanine oxidation and the percent of phenylalanine dose 
oxidized, indicating that folate and betaine have an equal capacity to remethylate 
methionine for protein synthesis.   
Although both folate and betaine function as remethylation nutrients, there are few 
studies comparing folate and betaine and their respective capacity to reform methionine.  
Experiments in rat hepatocytes have demonstrated that homocysteine is partitioned 
equally between both remethylation pathways [29].  Furthermore, following an 
intravenous bolus infusion of [
2
H7]methionine in folate or choline deficient rats, plasma 
[
2
H4]homocysteine was higher in folate deficient animals during the 120 minute 
experiment compared to both choline deficient and control groups; however, levels of 
remethylated methionine in the plasma were not different among the three groups.  In 
keeping with our findings, these results suggest an equal capacity for folate and betaine to 
remethylate methionine while higher levels of [
2
H4]homocysteine following folate 
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deficiency is likely the result of hepatic and renal localization of BHMT while MS is 
ubiquitous [30].  Our study adds to this body of knowledge by comparing the capacity of 
these two nutrients in neonatal animals and similar to adult rats, both nutrients can 
equally reform methionine for protein synthesis when methionine is first limiting.  
In order to determine the capacity for folate and betaine to reform methionine, it was first 
necessary to limit the availability of these remethylation nutrients.  To create a deficiency 
in these nutrients, we fed piglets an IG elemental diet moderately deficient in methionine 
and devoid of folate, betaine and choline for 6 days.  The effectiveness of the methyl 
group deficient diet is evident by the lower plasma levels of related metabolites on day 7 
compared to baseline.  Although bacterial folate synthesis in the large intestine can 
contribute to plasma folate status [31], we still observed a significant 65% reduction in 
plasma folate.  Moreover, in addition to a 70% lower plasma concentration of choline, 
betaine was depleted by day 7.   
Studies have demonstrated that folate deficiency leads to an increase in plasma 
homocysteine concentrations; [33,34] however, we did not observe this outcome, possibly 
as a result of the concurrent ~30% restriction in dietary methionine, potentially limiting 
flux through transmethylation and subsequent formation of homocysteine.  Deletion of 
the BHMT gene in mice leads to higher levels of homocysteine in the plasma and 
interestingly, supplementation with folate does not lead to normalization of homocysteine 
concentrations in these animals [35], highlighting the importance of betaine as a 
remethylation nutrient. We did observe a ‘rescue’ effect of methyl nutrients to lower 
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homocysteine concentrations, but could not discern the effectiveness of folate versus 
betaine on this outcome. 
Our data demonstrate that folate and betaine, either individually or together, equally 
increased protein synthesis as well as lowered plasma homocysteine in piglets receiving a 
diet that was first limited in methionine, suggesting that these nutrients have an equal 
capacity to remethylate methionine when limiting in the neonatal diet.  One limitation of 
this study is the lack of an experimental group receiving no supplementation which would 
demonstrate whether the lower phenylalanine oxidation on day 9 is a result of 
supplementation or age.  However, because the age range of the piglets studied is 4 days 
and there is no difference in protein synthesis in 1 versus 3 week old piglets (9), it is 
likely that the lower phenylalanine oxidation on day 9 is due to provision of methyl 
donors, rather than an age-related change. Moreover, our infusions and oxidation rates are 
corrected for body weight, so these changes are not due to growth.  The observation that 
folate and betaine can affect the availability of methionine is important as the levels of 
both sulfur amino acids and remethylation nutrients are variable in the neonatal diet.  This 
makes it important for future studies to further investigate the methionine requirement of 
the neonate in relation to other nutrients that converge on methionine metabolism.   
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CHAPTER 5: Guanidinoacetate is effective at increasing muscle creatine stores but 
limits methionine availability in Yucatan miniature pigs 
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Background: Creatine is an important energy buffer in tissues with a high energy demand 
such as muscle and brain, and is consequently a highly consumed nutritional supplement.  
Creatine is synthesized via the S-adenosylmethionine dependent methylation of 
guanidinoacetate (GAA), which is proportional to GAA availability.   
Objectives: The first objective of this study was to determine the effectiveness of GAA at 
increasing tissue creatine stores.  Because SAM is required for other methylation 
reactions, we also wanted to determine whether an increased creatine synthesis would 
lead to a lower availability of methyl groups for other methylated products.   
Methods: Three month-old pigs (n=18) were fed control, GAA- or creatine-supplemented 
diet twice daily. On day 18, anesthesia was induced 2-3 hours post feeding and a bolus of 
[methyl-
3
H]methionine was intravenously infused. After 30 min, the liver was analyzed 
for methyl-
3
H incorporation into protein, creatine, PC and DNA.   
Results: Although both creatine and GAA led to higher hepatic creatine concentration, 
only supplementation with GAA led to higher levels of muscle creatine (P < 0.05). Only 
GAA supplementation resulted in lower methyl-
3
H incorporation into PC and protein as 
well as lower hepatic SAM concentration compared to the controls. This suggests that 
creatine synthesis resulted in a limited methyl supply for PC and protein synthesis.   
Conclusions: Although GAA is more effective than creatine at supporting muscle creatine 
accretion, further research should be conducted into the long term consequences of a 





5.2  Introduction 
In the cell, creatine functions as an energy buffer via its conversion to phosphocreatine 
and subsequent restoration of ATP by the enzyme creatine kinase.  In an omnivorous 
adult, both diet and endogenous synthesis play an equal role in replenishing the daily 
creatine loss (1) of approximately 1.7% per day (2).  Endogenous creatine synthesis is 
primarily a dual organ process originating in the kidney with the synthesis of GAA from 
arginine and glycine by the enzyme AGAT.  GAA is taken up primarily by the liver and 
converted to creatine by GAMT which transfers a methyl group to GAA from SAM, a 
universal methyl donor synthesized from methionine (3).   
 
Creatine has been extensively studied as a nutritional supplement to improve exercise and 
sports performance (4-6) and has recently gained attention as a potential neuroprotectant 
and therapeutic agent for neurodegenerative disease (7-9). The agriculture industry has 
also been interested in creatine as a feed supplement due to its role in energy metabolism 
and its demonstrated ability to spare arginine (10).  Supplementation of creatine in pigs 
leads to greater weight gain (11), as well as higher levels of phosphocreatine in loin 
muscle, which consequently improves the negative effects of post mortem lactate 
formation (12).  More recently, GAA’s favorable cost and stability attributes have led to 
consideration of GAA as an alternative to creatine supplementation (13).  In chicks fed an 
arginine-deficient diet, both GAA and creatine supplementation resulted in a higher 
gain:feed ratio (14).  Moreover, GAA supplementation to a creatine-deficient diet in 
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chicks effectively increased levels of muscle creatine and breast muscle yield (15). 
Human studies have also demonstrated a dose response effect of GAA supplementation 
on plasma levels of both GAA and creatine, but tissue levels were not measured (16). The 
first objective of this study was to determine whether GAA or creatine was more effective 
at enhancing the tissue stores of creatine in pigs.  
 
However, the possible metabolic consequences of GAA supplementation must also be 
examined.  Hepatic synthesis of creatine utilizes a significant proportion of methyl groups 
(17), which could potentially limit methyl availability for other important 
transmethylation products such as phosphatidylcholine (PC) and methylated DNA.  
Furthermore, because the methyl group donated by SAM originates from methionine, 
increasing methyl group demand for creatine synthesis could potentially limit methionine 
availability for protein synthesis.  Indeed, we have recently shown in suckling piglets that 
an acute hepatic infusion of
 
GAA doubled methyl incorporation into creatine and 
simultaneously reduced methyl incorporation into PC by 80%, and methyl incorporation 
into protein by 40% (18).  Supplemental creatine also has the potential to spare methyl 
groups via negative feedback on AGAT activity (19), lowering GAA production and the 
demand for methyl groups used in creatine synthesis.  Indeed, because creatine synthesis 
is not feedback regulated in rats (20) and piglets (18), GAA supplementation will 
consume methyl groups without feedback regulation on GAMT. The second objective of 
this study was to determine the effect of dietary GAA and creatine supplementation on 




5.3  Materials and Methods  
Reagents. L-[Methyl-
3
H]methionine was obtained from American Radiolabeled 
Chemicals, Inc. (St. Louis, MO). All other chemicals were of analytical grade and were 
from Sigma (St. Louis, MO) or Fisher Scientific (Fair Lawn, NJ). 
Animals. All animal handling procedures were approved by the Institutional Animal Care 
Committee in accordance with the guidelines of the Canadian Council on Animal Care. 
Eighteen Yucatan miniature pigs (14-16 weeks old) were obtained from Memorial 
University of Newfoundland breeding colony and weight-matched to control (n=6), GAA 
supplemented (n=6) or creatine supplemented (n=6) groups.  Pigs were group housed and 
they received a standard pig grower diet which was fed twice daily.  Supplemental GAA 
(157 mg/kg/day) or creatine monohydrate (200 mg/kg/day) was mixed with an aliquot of 
grower feed and hand fed to experimental groups during each feeding for 18-19 days.  
The supplementation level in this study roughly corresponds to a typical creatine dosing 
schedule (i.e., 20 g/d loading, 2-5 g/d maintenance) used by humans to increase muscle 
creatine levels and achieve positive ergogenic effects (21,22).  On the final day of 
supplementation, pigs received their morning feeding and within 2-3 hours, anesthesia 
was induced with isoflurane (1-2%) in oxygen (1.5 L/min).  Catheters were inserted into 
the right and left jugular veins; pigs received an intravenous bolus infusion of 0.75 mCi 
L-[methyl-
3
H]methionine via one catheter while the other was used to sample blood 
before and every 7 min after the bolus infusion.  Thirty min following the infusion, a 
laparotomy was performed using cautery and the liver, right kidney, heart, brain and 
sample of bicep femoris muscle were immediately excised and freeze clamped.  A 
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labeling period of 30 min following the bolus of L-[methyl-
3
H]methionine was chosen 
based on a previous study (18) demonstrating that incorporation of label into DNA and 
PC was linear from 30-60 min while incorporation into creatine was constant during that 
time (data not shown). 
Plasma and tissue metabolite concentrations (See A.4 and A.5).  Plasma creatine and 
GAA and liver GAA concentrations were determined by HPLC following derivatization 
with ninhydrin (23). SAM and S-adenosyl-L-homocysteine (SAH) concentrations were 
determined by HPLC (24). Plasma and liver amino acid concentrations were determined 
by HPLC using phenylisothiocyanate derivatization (25). Plasma samples were first 
deproteinized with 0.5% trifluoroacetic acid in methanol. Liver samples were 
homogenized in perchloric acid; the supernatant was used to determine free amino acids 
and the protein pellet was hydrolyzed in 6 M HCl for 24 h and used to determine tissue-
bound amino acids. The SRA of SAM (DPM/µmol) was determined by fraction 
collecting the peak and DPM were determined by scintillation counting (Perkin Elmer 
Canada Ltd, Woodbridge, ON, Canada).  
Hepatic analyses of methylated products (See A.1-A.4). Creatine SRA and total creatine 
concentration was determined using a modified method (18) of Lamarre et al., (26).  For 
PC analyses, lipids were extracted from liver using the method by Folch et al. (27) and 
separated via thin layer chromatography as previously described (18). Total phosphorus 
was determined using a modified Bartlett method (28) and PC SRA was determined by 
scintillation counting (18). DNA was extracted and SRA (DPM/µg) was determined as 
previously described (18).  
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Calculations. The rate of 
3
H-methyl incorporation into methylated products and liver 
protein in 30 min was calculated as: 
Rate of 
3
H-methyl incorporation product = (SRAproduct /SRAprecursor) × 100,  
 where the precursor was hepatic SAM.  Due to contamination of the tissue free 
methionine pool with labelled methionine from blood, SAM was also used as a 
representative precursor for protein synthesis as it is well equilibrated with intracellular 
free methionine.  
Statistical analyses. Data are presented as means ± SD.  Groups were compared using 
one-way ANOVA with Newman-Keuls Multiple Comparison post-tests when main 
effects were identified. Hepatic GAA concntrations were not normally distributed as 
determined by the D’Agostino Pearson normality test and non-parametric Kruskal-Wallis 
analysis was used to determine differences among groups with Dunns post-tests when 
main effects were identified (GraphPad Prism 4.0 for Windows, GraphPad Software, San 
Diego, CA). Differences were considered significant at P < 0.05.  
5.4  Results 
Body weight.  The percent body weight gain from day 0 to day 18 of supplementation was 
23% ± 6%, 22% ± 4% and 28% ± 5% for control, creatine supplemented and GAA 
supplemented pigs, respectively, with no difference among groups. 
Tissue and plasma creatine and GAA. Compared to control pigs, GAA and creatine 
supplementation led to a 7.3- and 3.9-fold higher hepatic creatine concentrations, 
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respectively, and hepatic creatine was ~1.9-fold higher with GAA versus creatine 
supplementation (Table 5.1).  Muscle creatine was 19% higher in GAA supplemented 
pigs compared to control pigs while creatine supplementation was intermediate with no 
difference from control or GAA diets.  Both creatine and GAA supplementation led to a 
higher creatine concentration in the kidney versus to the control group, while the creatine 
concentration in the heart was not different among groups.  GAA concentration was 
higher in the kidney following GAA supplementation compared to both other groups with 
no differences in the heart or muscle (Table 5.1).  Hepatic GAA was highr in pigs 
supplemented with GAA compared to controls (Figure 5.1).  Plasma creatine 
concentrations were 66% higher than control with GAA supplementation and 140% 
higher with creatine supplementation; moreover, creatine supplementation led to 40% 
higher creatine concentrations compared to GAA supplementation (Table 5.2).  Plasma 
GAA concentrations were higher with GAA supplementation compared to both creatine 
and control groups (Table 5.2).    
Rate of 
3
H-methyl incorporation into transmethylation products.  In GAA supplemented 
pigs, the rate of 
3
H-methyl incorporation into creatine was 3.9-fold and 2.7-fold higher 
than control and creatine supplemented pigs, respectively (Table 5.3).  Compared to 
control supplemented groups, GAA supplementation also resulted in a 78% lower 
3
H-
methyl incorporation into PC and 55 % lower 
3




Table 5.1  Tissue distribution of creatine and GAA
1
 in pigs fed a control, creatine 




Control Creatine GAA 
                          Creatine, µmol/g wet weight 
Liver 0.429 ± 0.14a 1.674 ± 0.61b 3.125 ± 1.32c 
Muscle 39.9 ± 2.42a 44.08 ± 4.10ab 47.63 ± 4.25b 
Kidney 0.418 ± 0.08a 1.132 ± 0.38b 0.853 ± 0.19b 
Heart 19.22 ± 4.49 18.07 ± 2.87 19.34 ± 3.99 
               GAA, nmol/g wet weight 
Liver 7.38 ± 2.7a 16.8 ± 10ab 1323 ± 1796b 
Muscle 44.2 ± 14 73.7 ± 43 92.0 ± 36 
Kidney 81.21 ± 23a 97.21 ± 29a 230 ± 83b 





Data are means ± SD; n = 6. Means with different superscripts are significantly different 

































Figure 5.1 Hepatic GAA
 
concentration in pigs fed a control, creatine supplemented or 




Table 5.2 Plasma concentrations of metabolites in pigs fed a control, creatine 
supplemented or GAA
1
 supplemented diet for 18 days
2
 
 Control Creatine GAA 
 µmol/L 
Homocysteine 17.8 ± 1.5a 16.1 ± 1.7a 34.2 ± 13.3b 
Cysteine 50.3 ± 7.4 48.5 ± 7.2 60.4 ± 9.5 
Glutathione 43.6 ±  6.8 49.5 ±  8.7 37.1 ±  6.2 
Creatine 112 ± 45a 264 ± 59c 186 ± 37b 





Data are means ± SD; n = 6. Means with different superscripts are significantly different 




Table 5.3  Rate of 
3
H-methyl incorporation into transmethylation products and protein 
after 30 minutes (corrected for SAM) in pigs fed a control, creatine supplemented or 
GAA supplemented diet for 18 days
1
 
 Control Creatine GAA 
                       Rate of 3H-methyl incorporation2 
Creatine  23.2 ± 7.0a 32.5 ± 12.6a 89.4 ± 45.3b 
PC 4.24 ± 1.40b 3.34 ± 0.86b 0.95 ± 0.51a 
DNA 248 ±  90 249 ± 71 193 ± 42 
Protein 2.73 ± 0.87b 2.48 ± 0.69b 1.22 ± 0.42a 
    
 
1
Data are means ± SD; n = 6. Means with different superscripts are significantly different 
within rows, P < 0.05. GAA, guanidinoacetate; PC, phosphatidylcholine; SAM, S-
adenosylmethionine; SRA, specific radioactivity.   
2
Corrected rate of 
3






protein, with no difference between creatine supplemented and control pigs.  There were 
no differences in 
3
H-methyl incorporation into DNA or in the SRA of SAM among 
groups (Table 5.3) 
Plasma and liver metabolite concentrations.  Supplementation with GAA resulted in a 
44% lower hepatic SAM concentration versus both control and creatine supplemented 
groups; there were no differences in hepatic SAH or SAM/SAH ratio among groups 
(Table 5.4).  There were also no differences in hepatic methionine, arginine or PC among 
groups.  GAA supplemented pigs had a 1.9-2.1-fold higher plasma homocysteine 
compared to control and creatine supplemented pigs, with no difference in plasma 
cysteine or glutathione among groups (Table 5.2). 
5.5 Discussion 
We supplemented young pigs with equimolar amounts of either GAA or creatine for 18 
days and found that while both GAA and creatine supplementation led to higher creatine 
concentrations in the liver and kidney compared to control pigs, GAA supplementation 
was more effective than creatine at increasing hepatic creatine concentrations.  Although 
GAA supplemented pigs had a higher concentration of muscle creatine compared to 
control pigs, there was no difference in muscle creatine between creatine and GAA 
supplemented pigs suggesting that GAA is not more effective than creatine at increasing 
muscle creatine stores.   
Because of the positive ergogenic and therapeutic effects of creatine, the use of dietary 





Table 5.4 Hepatic concentrations of metabolites in pigs fed a control, creatine 
supplemented or GAA supplemented diet for 18 days
1
 
 Control Creatine GAA 
                                   nmol/g wet weight 
Arginine  43.2 ± 4.6 64.3 ± 35.5 41.6 ± 4.1 
Methionine  99.1 ± 38.4 99.3 ± 30.1 86.6 ± 28.5 
SAM 56.9 ± 8.4b 66.5 ± 22..6b 31.9 ± 16.5a 
SAH 15.1 ± 2.8 15.4 ± 2.6 18.3 ± 11.8 
SAM/SAH 3.94 ± 1.24 4.35 ± 1.50 2.46 ± 1.68 
SAM SRA 114 ± 28 127 ± 33 144 ± 47 
PC (umol/g) 8.1 ± 2.2 8.5 ± 2.4 6.9 ± 2.9 
1
Data are means ± SDs; n = 6. Means with different superscripts are significantly 
different within rows, P < 0.05. DPM, disintegrations per minute; GAA, 






interest.  Although experiments in both humans and animals have demonstrated that 
dietary creatine supplementation can be an effective means to increase muscle creatine  
(22), some studies have yielded inconsistent findings (29).  Similar to our results, the 
relative increase in tissue creatine following supplementation is higher in tissues with low 
levels of basal creatine (i.e., kidney and liver) compared to tissues with high basal 
creatine concentrations (i.e., skeletal muscle, heart and brain) (29, 30).  Although 
supplementation with either creatine or GAA had no significant effect on muscle, it is 
interesting that GAA supplementation was more effective than creatine supplementation 
at increasing concentrations in the liver.  Because the liver is the primary site for creatine 
synthesis, the higher level of hepatic creatine following GAA supplementation is a result 
of endogenous synthesis in the liver.    
Skeletal muscle has a limited capacity to store creatine (22) and it has been proposed that 
individuals classified as “non-responders” to creatine supplementation have higher initial 
creatine concentrations (31).  Because of both the limited creatine storage capacity of 
skeletal muscle (22) and the high relative basal creatine concentration of the bicep 
femoris muscle (32) sampled in this study, it is possible that despite an increase in plasma 
creatine concentrations, the creatine concentration of the muscle sampled in this study 
was at a maximal creatine storage capacity prior to supplementation.  Indeed, others have 
shown that white gastrocnemius muscle had lower creatine uptake following 
supplementation when compared to a pre-supplementation rate, a finding that was not 
observed in other muscle types with lower basal creatine concentrations (33). Higher 
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concentrations of extracellular creatine have been shown to downregulate creatine 
transport into rat muscle, with 50% inhibition occuring at physiological creatine 
concentrations (34). Thus, it is possible that the higher plasma creatine levels found in our 
creatine and GAA supplemented pigs led to downregulation of the creatine transporter.   
We previously demonstrated in an acute model of GAA supplementation that creatine 
synthesis is not feedback regulated at GAMT (18), and others have produced the same 
effect in rats (20).  In this study, we investigated whether chronic supplementation of 
GAA would increase creatine synthesis thereby limiting methyl group availability for 
other methylation reactions.  As expected, dietary supplementation with GAA led to a 
higher rate of incorporation of methyl groups into creatine (Table 5.3).  Concomitantly, 
the chronic dietary supplementation with GAA also resulted in reduced methyl 
incorporation into both PC and protein, with no change in incorporation into DNA.  These 
results are in keeping with our previous findings of increased methyl incorporation into 
creatine and lower methyl incorporation into PC and protein (protein synthesis) following 
an acute intraportal infusion of GAA in piglets (18).  Interestingly, chronic creatine 
supplementation in this study did not affect methyl group partitioning and does not appear 
to spare methyl groups for other transmethylation reactions.   
Although an omnivorous adult human typically synthesizes half of their creatine 
requirement (1), it is not known whether this is similar in a weaned pig.  In this study, the 
pig grower diet provided 0.05 mmol/kg/day of creatine via meat meal (35), which is ~5% 
of the total creatine accrued by a growing piglet (i.e., ~0.8 mmol/kg/day) (36).  With 
minimal creatine provided in the diet, it is likely that the pigs in this study must have 
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synthesized the vast majority of their creatine needs.  Based on this assumption, the GAA 
concentration in our diet (1.53 mmol/kg/day) provided approximately twice the amount 
required to synthesize the daily creatine requirement.  Doubling the methyl group 
requirement for creatine synthesis via GAA supplementation helps explain the limited 
methyl availability for other transmethylation reactions.  This hypothesis is supported by 
the lower hepatic SAM concentration in GAA supplemented pigs which interestingly was 
not accompanied by a lower hepatic concentration of the transmethylation product SAH, 
a known inhibitor of transmethylation reactions (37).  Given the higher levels of plasma 
homocysteine with GAA supplementation, it is likely that SAH was readily converted to 
homocysteine and exported into the plasma.   
In this study we demonstrated that GAA supplementation leads to higher levels of 
creatine in the muscle compared to control pigs but is not more effective than creatine at 
increasing muscle creatine stores. The higher methyl group utilization for creatine 
synthesis following supplementation with GAA can lead to a limited methyl group supply 
for other transmethylation reactions.  Although a 6 week GAA supplementation trial in 
humans concluded that GAA is safe with a low incidence of biochemical abnormalities 
and an acceptable side-effects profile (38), the potential for GAA supplementation to 
limit protein and PC synthesis in a growing animal is concerning and warrants 
consideration.  However, total hepatic PC concentration was not different in GAA 
supplemented pigs, likely because PEMT is thought to be responsible for only ~30% of 
hepatic PC synthesis, with the remainder synthesized by the enzyme CDP-choline:1,2-
diacylglycerol cholinephosphotransferase (39).  It is possible that this alternate pathway 
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for PC synthesis compensated for lower PC synthesis via PEMT.  Because we 
supplemented with GAA twice daily, it is possible that the limited methyl group 
availability is an acute post-prandial response to GAA, so future studies should 
investigate long term outcomes with respect to methyl group incorporation and protein 
synthesis. In particular, the 40% lower incorporation into protein with GAA 
supplementation is likely an acute effect considering growth was not affected in these 
pigs, although body composition was not assessed.  In spite of the effectiveness of GAA 
at enhancing creatine stores, more research is needed to clarify the potentially detrimental 
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Chapter 6.  General Discussion 
The research presented in this thesis focuses on methionine metabolism and requirements 
during development, while considering other nutrients that converge on methionine 
metabolic pathways.  Our main objective was to investigate how variation in either the 
supply or demand of methionine can impact methionine availability for its various 
functions.  The following discussion serves to highlight and bridge the primary findings 
of this thesis while addressing questions that warrant further investigation.     
6.1 IUGR and methionine metabolism 
Epidemiological studies supporting the fetal programming hypothesis and the association 
of low birth weight with disease in later life have led to extensive research in animal 
models to elucidate the specific mechanisms that result in the adverse effects in 
adulthood.  Studies involving protein restriction have led to the hypothesis that one of the 
specific nutrient perturbations responsible for these outcomes may be an imbalance of 
dietary methionine in relation to other amino acids (Langley-Evans, 2000; Rees et al., 
2006).  Furthermore, it has been demonstrated that high homocysteine concentrations 
during gestation are associated with growth restriction (Gadhok et al., 2011).  Because 
IUGR is associated with epigenetic changes to DNA methylation (MacLennan et al. 
2004), the study presented in Chapter 2 was designed to determine whether IUGR piglets 
have a perturbed methionine metabolism.   
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Using neonatal growth restricted and normal weight littermates, we determined that 
IUGR piglets appear to have a reduced capacity to catabolize homocysteine as 
demonstrated by lower activity levels of both the remethylation enzyme BHMT and the 
transsulfuration enzyme CGL.  Although hyperhomocysteinemia would be expected in 
these animals, homocysteine was not elevated and it was in fact lower in the liver of the 
growth restricted piglets.  Dietary intake was not controlled in this study and it is possible 
that methionine intake in suckling IUGR piglets did not exceed the capacity of BHMT 
and CGL to dispose of homocysteine.  In addition to the low methionine/cysteine ratio of 
1.4 found in sow’s milk (Davis et al., 1994), IUGR piglets likely have lower nutrient 
absorption resulting from the disturbed morphology of the small intestine (D'Inca et al., 
2010; Wang et al., 2005) and the lower expression of jejunal neutral amino acid 
transporters in the first week of life (Yang et al., 2012).  Furthermore, methionine has 
been suggested as a first limiting amino acid in piglets due to a significant first pass use 
of methionine by the gut (Stoll et al., 1998).   
When considering the high methionine flux in the neonate (Bauchart-Thevret, et al. 2009; 
Thomas et al., 2008), the lower BHMT activity found in IUGR piglets suggest that 
methionine may be limiting in these animals.  Although plasma and hepatic levels of 
methionine, as well as hepatic levels of SAM, were not different between normal weight 
and growth restricted piglets, metabolite concentration is a static measure giving limited 
information about in vivo dynamic flux.  Neonatal piglets fed a diet deficient in sulfur 
amino acids have similar levels of hepatic methionine compared to controls; however, 
methionine flux, including remethylation rate, is lower (Bauchart-Thevret et al., 2009).  
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Although we found no difference in DNA methylation in IUGR piglets, it is possible that 
methionine availability was limited for other more quantitatively significant 
transmethylation reactions or protein synthesis.  This speculation led us to ask, is 
methionine limiting for protein synthesis or transmethylation reactions in IUGR piglets? 
6.1.1  IUGR and methionine partitioning  
The study presented in Chapter 3 was in part designed to address some of the 
uncertainties remaining from the work presented in Chapter 2.  Specifically, we wanted 
to determine whether methionine is limiting for either protein synthesis or 
transmethylation reactions in IUGR piglets, as well as to determine if the partitioning of 
methionine among transmethylation reactions is different in these animals.  Using a bolus 
intraportal infusion of [
3
H]methyl-methionine in 21 day old IUGR and normal weight 
piglets, we determined that of the label recovered, 51% of hepatic methionine was 
partitioned towards protein synthesis in IUGR piglets compared to 32% in normal weight 
animals.  Although the methionine incorporation into hepatic protein was not significantly 
higher in IUGR piglets, growth restriction led to lower incorporation of methyl groups 
into PC.  Because IUGR piglets have been shown to have a higher feed efficiency 
(Ritacco et al. 1997), it is possible that more methionine is partitioned towards protein 
synthesis for compensatory growth; however, this hypothesis has been contradicted by 
demonstration of no difference in hepatic protein synthesis following growth restriction 
(Davis et al. 1997).  Furthermore, it has also been demonstrated that catch up growth 
following growth restriction is accompanied by greater adiposity compared to littermates 
(Myrie et al., 2012).  In Chapter 2 we hypothesized that IUGR piglets have a lower total 
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methionine flux and this may limit the availability of methionine for PEMT as protein 
synthesis is pritorized when sulfur amino acids are limiting (Bauchart-Thevret et al., 
2009).   
Alternatively, because protein synthesis is prioritized over transmethylation during sulfur 
amino acid deficiency (Bauchart-Thevret et al., 2009), it is possible that lower methionine 
availability in IUGR piglets led to a higher fraction of methionine flux towards protein 
synthesis, consequently limiting availability of methionine for synthesis of PC; however, 
in Chapter 3 we determined partitioning of methionine and can only speculate on 
absolute rates of methionine flux.  Future work should focus on use of the established 
primed/constant stable isotope methionine infusion (Bauchart-Thevret et al., 2009) to 
calculate whole body methionine kinetics in IUGR piglets.  Determination of absolute 
rates of remethylation, transsulfuration, transmethylation and protein synthesis would 
allow us to determine whether methionine is limiting in these animals resulting in a lower 
methionine metabolism.   
Although determining methionine kinetics would offer valuable insight into methionine 
metabolism in IUGR, the question of whether MS functions to compensate for lower 
BHMT activity could not be evaluated from the quantification of a single remethylation 
rate accounting for both remethylation pathways.  When considering nutrient 
requirements in the neonate, this is an important question because deficiency of one 
remethylation nutrient (folate or betaine/choline) leads to compensation of the alternate 
remethylation pathway, resulting in lower levels of the corresponding nutrient (Kim et al., 
1994; Selhub et al. 1991). If flux through MS is increased in IUGR piglets to compensate 
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for lower activity of BHMT, more dietary folate may be required in these animals to 
maintain folate stores and it is possible that flux through MS could become limited by 
folate availability.  Piglets are born with low folate stores and plasma folate concentration 
increases ~3-fold in the neonatal piglet during the first 2 days (Barkow et al., 2001) 
making it important to determine whether folate status is affected by IUGR during the 
first few days of life.     
Although we did not demonstrate elevated homocysteine in IUGR piglets in this thesis, as 
highlighted in Chapter 2, the methionine/cysteine ratio of bovine casein, commonly used 
in infant formula, is 2-3 fold higher than in sow’s milk.  Because of the lower hepatic 
activity of BHMT and CGL in growth restricted piglets, a casein based diet may result in 
an insufficient capacity to metabolize homocysteine resulting in hyperhomocysteinemia.  
Furthermore, because levels of cysteine and taurine were low in sow fed IUGR piglets 
due to lower CGL activity, a diet requiring a higher flux through transsulfuration to meet 
cysteine requirement may lead to a further reduction in cysteine and taurine compared to 
normal weight piglets.  Although ~90% of Canadian women initiate breastfeeding, after 3 
months only 50% of infants are exclusively breast fed (Chalmers et al., 2009) making it 
important to understand how casein based infant formulas affect methionine metabolism 
in IUGR.  Comparing methionine kinetics in casein fed and sow fed IUGR piglets would 
provide further insight into an optimal diet following growth restriction.  Additionally, 
early folate status should also be investigated in IUGR piglets consuming a casein based 
diet as flux through MS may be higher to accommodate a higher methionine flux in these 




Although the Kennedy pathway is used to synthesize 70% of hepatic PC, the fatty acid 
composition of PC produced via PEMT is distinct from that of the Kennedy pathway, 
with PEMT being responsible for the mobilization of the essential fatty acids 20:4(n-6) 
and 22:6(n-3) from liver into plasma (Watkins et al., 2003); these fatty acids are very 
important for brain development during early life  Indeed, the DHA content of plasma PC 
has been suggested to be a surrogate marker for hepatic PEMT activity in humans (Da 
Costa et al., 2011).  Because we found lower incorporation of methyl label into PC in 
IUGR piglets, future work should investigate whether the fatty acid composition of PC 
differs between IUGR and normal weight pigs.  
Although the Km for PC synthesis via PEMT has not been determined in the pig, in the rat 
the hepatic Km for SAM for the rate limiting first step in PC synthesis via PEMTis 18 µM 
(Hoffman et al., 1981) which is 13 nmol/g considering a 70% water content of the liver.  
The hepatic SAM concentration in the rat is 69 nmol/g (Hoffman and Cornatzer, 1981) 
and it is possible that the 50% lower level of hepatic SAM found in both our acute and 
chronic GAA supplemented pigs was below the Km for the first reaction of PC synthesis 
via PEMT in these animals. The Kennedy pathway can function to compensate for 
reduced PC synthesis in PEMT knockout mice (Walky et al., 1997), which have 
minimally affected levels of hepatic PC; however, when fed a high fat diet, these animals 
develop hepatomegaly and steatosis and it is possible that the lower methyl incorporation 
into PC in IUGR piglets and during situations of high methyl demand may lead to altered 
liver morphology on a diet high in fat. 
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6.2  Methionine supply and demand 
Methionine availability is dependent on both the supply of methionine as well as the 
demand for its various functions.  Roughly 50% of methionine is partitioned towards 
transmethylation reactions in 1-week old piglets and approximately half of the resulting 
homocysteine is remethylated to methionine (Bauchart-Thevret et al., 2009).  This 
highlights the quantitatively significant contribution of transmethylation to methionine 
demand and of remethylation to methionine supply.  Because we speculate a lower 
remethylation capacity as well as a limited dietary supply of methionine in IUGR piglets, 
we wanted to further investigate the relative capacity of MS and BHMT to supply 
methionine when dietary methionine is limiting in the neonate.  Furthermore, we also 
wanted to determine how increasing the demand for one transmethylation product affects 
methionine availability for protein synthesis and other transmethylation reactions.   
In Chapter 3 we investigated the effect of increasing methionine demand for creatine 
synthesis on methionine partitioning in both normal weight and IUGR piglets.  Because 
the synthesis of creatine via GAMT is proportional to the availability of GAA (Da Silva 
et al., 2009), we decided to use an acute GAA infusion as a means to increase demand for 
creatine synthesis with the intent to limit methionine availability.  Although we 
hypothesized lower methionine availability in both normal weight and IUGR piglets, an 
increase in transmethylation flux in IUGR piglets may further limit methionine 
availability due to limited remethylation capacity.  In both normal weight and growth 
restricted piglets, delivering 1/3 of the GAA needed to synthesize the daily creatine 
requirement led to an increased incorporation of methyl groups into creatine and a lower 
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incorporation of methyl groups into protein and PC.  Infants receiving infant formula with 
minimal creatine, such as soy based formula, must synthesize the vast majority of their 
creatine requirement (Edison et al., 2013) which may limit methionine availability for 
growth and synthesis of PC.   
In Chapter 4 we focused on methionine supply, with the objective of determining 
whether folate and betaine have the capacity to reform methionine to increase its 
availability for protein synthesis when methionine is limiting in the diet.  In addition to 
examining methionine supply via remethylation, it was also our aim to compare the 
relative capacity of these two pathways in vivo.  We concluded that dietary provision of 
folate, betaine or a combination of both can indeed spare methionine for protein synthesis 
when methionine is limiting in the diet of neonatal piglets.   
To further support these findings, we also determined that folate and betaine could 
equally lower plasma homocysteine, the precursor for endogenous methionine synthesis.  
Both betaine and folate have been investigated as a means to lower homocysteine (Keser 
et al., 2013; McRae, 2013); however, there appear to be no controlled animal experiments 
directly comparing these nutrients in their capacity to lower homocysteine.  Betaine has 
been shown to be effective at lowering GAA induced hyperhomocysteinemia in rats 
(Setoue et al., 2008). Furthermore, GAA supplemented humans receiving concurrent 
supplementation with betaine, folate, and vitamins B6 and B12 exhibit no incidence of 
hyperhomocysteinemia compared to hyperhomocysteinemia in ~50% of the control group 
(Ostojic et al., 2013).  Repeating our bolus [
3
H]methyl-methionine infusion in GAA 
 149 
 
supplemented piglets receiving either folate or betaine would help evaluate which 
remethylation pathway has a higher maximum capacity in the neonate.       
The results from Chapter 3 and Chapter 4 demonstrate the complexity in determining 
the methionine requirement as both a high demand for transmethylation products and the 
supply of remethylation nutrients can affect the availability of methionine for protein 
synthesis in the growing neonate.  The methionine requirement has been established in 






 with the provision of excess dietary cysteine; however, the diet 
used in that study was also devoid of creatine and it provided 115% of the folate 
requirement while using a choline rich fat source (Shoveller et al., 2003b).  Because 
dietary cysteine can spare the methionine requirement by 40% (Shoveller et al, 2003a) 
our results suggest that other nutrients, such as folate, betaine, and creatine, also have the 
potential to increase methionine availability and spare the methionine requirement, a 
concept that has been proposed for humans previously (Fukagawa, 2006).   
The IAAO technique presented in Chapter 4 can be used to determine the methionine 
requirement by increasing dietary methionine levels and determining the rate of 
phenylalanine oxidation until a plateau is reached.  This “breakpoint” indicates the 
maximum amount of phenylalanine that is being incorporated into protein and methionine 
is no longer limiting (Shoveller et al., 2003b).  Determining the methionine requirement 
in piglets fed diets deficient or replete in folate, betaine or creatine to determine and 
quantify the capacity of each nutrient to spare methionine would provide insight into the 




Although in Chapter 4 we used betaine in our remethylation experiment as a more direct 
entry into the remethylation pathway compared to choline, betaine intake in infants is 
minimal and the majority of betaine is produced via choline oxidation (Fischer et al., 
2010).  Consequently, the question of whether choline supplementation can also spare 
methionine for protein synthesis should be determined.  The effectiveness of choline 
relative to betaine likely depends on the form of choline used, as ~85% of choline and 
phosphocholine are converted to betaine within 24 hours in rats while only ~50% of 
glycerophosphocholine and 13% of PC are found as betaine (Holmes-McNary et al., 
1996).  Based on the composition of human milk, ~65% of total choline intake is 
converted to betaine after 24 hours (Ilcol et al., 2005), while a diet providing free choline 
would lead to a ~20% higher conversion to betaine.  Experiments in pigs have 
demonstrated that either betaine or choline supplementation of diets deficient in 
methionine equally increase hepatic BHMT activity (Emmert et al., 1998), suggesting 
choline would have the same capacity as betaine to reform methionine for protein 
synthesis; however, choline deficiency in rats leads to a doubling of hepatic PEMT 
activity to form endogenous choline (Cui and Vance, 1996).  Although choline likely has 
a similar capacity as betaine to reform methionine, it is possible that choline 
supplementation may lead to higher methionine availability for protein synthesis if less is 
required for PEMT.  Future work should not only determine the capacity of choline to 
increase methionine availability for protein synthesis, but experiments should also 
determine methionine partitioning during supplementation of a methionine deficient diet 
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with folate, betaine or choline to determine whether these nutrients lead to a different 
distribution of methionine among protein synthesis and transmethylation reactions.   
Although there has been extensive research published demonstrating the importance of 
choline during development (McCann et al., 2006; Zeisel, 2006), the role of choline as a 
source of methyl groups in the neonate has been less thoroughly examined.  Based on 
average intake (Dewey and Lönnerdal, 1983) and betaine concentrations in breast milk 
(Fischer et al., 2010), infants consume ~0.13 mg/kg per day of betaine while the average 
adult consumes ~5 mg/kg per day.  It appears that without dietary betaine, hepatic betaine 
levels remain constant pre and post weaning while hepatic BHMT activity increases in 
suckling rats from weeks 2-3 followed by a decline in activity (Clow et al., 2008).  
Because piglets are born more mature than the rat, it is possible that this transient increase 
in BHMT activity occurs during the first 2 weeks of life in the piglet which is in keeping 
with the higher methionine cycle activity found in 1 week old versus 3 week old piglets 
(Bauchart-Thevret et al., 2009).  It would be of interest to repeat the IAAO experiment 
performed in Chapter 4 using 3 week old piglets to determine whether our results are age 
specific.  Furthermore, activity levels of hepatic and renal choline dehydrogenase in the 













 respectively (Haubrich & Gerber, 1981).  Because activity levels 
found in human are more similar to pig (Emmert et al., 1998), determining levels of 
hepatic and renal betaine in suckling piglets would complement experiments examining 




6.3 Chronic high methyl demand and creatine supplementation 
The acute high methyl demand experiment presented in Chapter 3 led us to question 
whether a chronic high demand for creatine synthesis would also limit the availability of 
methionine for protein synthesis.  Our intention was to also perform this experiment in ~3 
week old piglets; however, piglet availability was not sufficient at the time of the 
experiment and 3 month old male pigs were used.  For Chapter 5, we supplemented 
GAA to 3 month old weaned pigs twice per day for ~18 days, which led to both a lower 
incorporation of methionine into protein and methyl groups into PC.  This demonstrates 
that both acute and chronic high demand for creatine synthesis can limit the availability of 
methionine for protein and PC synthesis. 
Because creatine supplementation has been shown to lower renal AGAT activity in rats 
(Da Silva et al., 2009), the second experiment presented in Chapter 5 was developed to 
determine whether chronic creatine supplementation can lead to lower demand for 
creatine synthesis and spare methyl groups for other transmethylation reactions.  After 
~18 days of creatine supplementation above the requirement for synthesis, we found no 
sparing effect on availability of methyl groups for protein synthesis or other 
transmethylation reactions.  It is likely that methionine was sufficient in these animals, 
and repeating the same experiment while providing a diet limiting in methionine would 





6.4  Creatine Accretion   
Because creatine has recently been shown to be a multifaceted nutrient with benefits to 
several diseases as well as serving its more common function as an ergogenic nutrient, we 
decided to compare the effectiveness of creatine and GAA at increasing tissue stores of 
creatine using 3 month old pigs.  We demonstrated that 18 days of dietary 
supplementation with GAA is more effective at increasing creatine in the liver than 
equimolar supplementation with creatine; GAA supplementation also led to higher 
muscle creatine concentrations than control, with creatine supplementation intermediate.   
Despite the important function creatine plays in muscle, information about the muscle’s 
capacity to synthesize creatine is limiting.  Mice lacking the creatine transporter have 
undetectable levels of creatine in the muscle while the level of creatine in the kidney is 
unchanged, demonstrating that the muscle is likely unable to synthesize creatine (Skelton 
et al., 2011).  Piglets have low levels of GAMT activity in the muscle while AGAT 
activity is undetectable (Brosnan et al., 2009) suggesting that the capacity for creatine 
synthesis in the muscle may be limited by GAA synthesis and availability.  It is also 
possible that SAM may be limiting for GAA methylation, since the levels of MAT 
activity are also low in the muscle of pigs (Brosnan et al., 2009).  Future experiments 
should determine the capacity for creatine synthesis by the muscle when GAA is not 
limiting. 
Another interesting outcome of this study was the lack of effect of creatine 
supplementation on plasma or tissue levels of GAA.  Interestingly, although creatine 
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supplementation leads to lower renal and pancreatic AGAT activity in rats,  renal and 
pancreatic GAA concentrations are in fact higher following creatine supplementation, 
possibly due to an effect of higher plasma creatine concentration on GAA export (Da 
Silva et al., 2014).  From this, we would expect lower levels of hepatic and plasma GAA, 
which was not found in our creatine supplemented pigs.  We speculated in Chapter 5 that 
unlike rats, the kidney may not be the primary site for GAA production in the pig.  
Although piglets have significant AGAT activity in the kidney, the AGAT activity in the 
pancreas is 5 fold higher, suggesting that the pancreas may be the primary site for GAA 
production (Brosnan et al., 2009) and it is possible that GAA production in pancreases of 
pigs may not be regulated via feedback inhibition of AGAT.  Because the kidney is 
responsible for an estimated 20% of total GAA production in humans (Edison et al., 
2007), pigs appear to have similarities to humans in whole body creatine metabolism and 
tissue contribution to GAA production should be further investigated in the piglet.  
6.5  General Conclusions 
The work presented in this thesis demonstrates the complexity in determining how the 
various components of the methionine cycle interact to affect methionine supply and 
demand.  IUGR piglets have both a lower maximum capacity for remethylation and also 
appear to have limited methionine availability for PC synthesis suggesting a lower 
methionine flux in these animals.  This thesis also demonstrates that increasing the 
demand for the synthesis of one transmethylation product can limit methionine 
availability for other transmethylation reactions as well as protein synthesis.  
Furthermore, nutrients involved in remethylation can equally increase methionine 
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availability for protein synthesis.  The synthesis of our results leads us to conclude that 
both the demand for methionine as well as the endogenous supply via remethylation, must 
both be considered when determining the recommended levels of dietary methionine in 
the neonate.  This is especially important considering nutrients such as choline and 
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Appendix A:  Methods 
A.1. Determination of phosphatidylcholine concentration and DPM 
Phosphatidylcholine was isolated using the method of Folch et al. (1956) followed by 
separation by TLC and quantification via a modified Bartlet method (1958).  
Approximately 70mg of liver was homogenized in 300 ul of 50 mM NaCl and transferred 
to a glass tube. 1.5 ml of chloroform and methanol (2:1) was added and samples were 
vortexed and left at 4 
o
C overnight.  The next day the samples were centrifuged at 3000 
rpm for 10 min and the lower organic layer was removed and evaporated under nitrogen.  
The residue was re-dissolved in 100 ul isopropanol and applied to a silica G-60 TLC 
plate.  The plate was inserted in a saturated TLC chamber (chloroform/methanol/acetic 
acid/water, 25:15:4:2) and left until the mobile phase has migrated up ¾ of the plate.  
Iodine was used for visualization of the plate and the band corresponding to the PC 
standard was scraped into a glass tube containing 300 ul perchloric acid.  The tubes were 
heated at 180 
o
C for 2 h until no dark colour was visible.  Samples were cooled and 
diluted with 1 ml water followed by addition of 50 ul of 5% ammonium molybdate and 
50 ul of a 1-amino-2-naphthol-4-sulfonic acid solution (1.0 g aminoapthalsulfonic acid in 
390 ml of 15% sodium metabisulfite plus 10 ml of 20% sodium sulfite) with vortexing 
between additions.  Tubes were then capped with marbles and samples were placed in a 
boiling water bath for 12 min. Absorbance was read at 815 nm by a spectrophotometer 
and a standard curve was used for quantification of total phosphorus.  A portion of the 




A.2 Determination of creatine concentration and DPM 
Tissue creatine concentration was determined following a modified method of Lamarre 
(2012).  Tissue was homogenized in 50 mM (pH 7.4) Tris buffer (1:4.5) and left at room 
temperature for 20 minutes to allow for conversion of phosphocreatine to creatine.  
Trifluoroacetic acid was added to the samples which were set on ice for 10 min followed 
by centrifugation at 6000 rpm at 4 
o
C for 10 min.  Samples were then filtered using a 
Bond-Elut C18 solid phase extraction cartridge and samples were separated via HPLC 
following injection of filtrate onto a Hypercarb column (100.03 x 4.6mm).  An isocratic 
mobile phase of 0.1% TFA and 3% methanol was used with a flow rate of 1 ml/min and 
run time of 18 minutes.  A standard curve was used for quantification and peaks were 
determined using Empower 2 software (Waters, Milford, MA).  Creatine was fraction 
collected for determination of DPM via liquid scintillation counting.   
A.3 Determination of DNA concentration and DPM 
DNA was extracted using phenol extraction.  Samples were homogenized in a buffer with 
50 mM pH8 Tris, 1% sodium dodecyl sulfate, 100 mM EDTA and 100 mM NaCl.  
Proteinase K was then added and samples were incubated overnight in a 56 
o
C water bath.  
An equal volume of PCI (phenol:chloroform:isoamyl alcohol 25:24:1) was added to 
samples which were then mixed and centrifuged for 15 min at 7000 rpm.  The top 
aqueous layer was removed and transferred to a fresh tube.  This extraction process was 
repeated several times until no protein interface was visible.  After transfer to a fresh 
tube, CIA (chloroform:isoamylalcohol: 24:1) was then added to the aqueous layer and 
 164 
 
centrifuged for 10 min after mixing.  The top layer was removed for DNA precipitation 
using an equal volume of isopropanol and 1/5 volume of 1 M sodium acetate.  DNA was 
washed twice in 70% ethanol and centrifuged in 95% ethanol for 10 min at 10,000 rpm.  
The ethanol was then removed and after drying, the remaining DNA pellet was 
resuspended in TE
-4 
buffer (10 mM Tris, 0.1 mM EDTA, pH 8).  DNA concentration was 
determined using a NanoDrop and DPM were determined with liquid scintillation 
counting.   
A.4 Determination of SAM/SAH concentration and SAM DPM 
Tissue SAM and SAH were determined using a method by Ratnam et al. (2006).  Tissue 
was homogenized in cold 8% TCA (1:5) and centrifuged at 12,000 rpm for 5 min.  
Samples were then filtered using a 45 um syringe filter and HPLC was used for 
separation following injection of filtrate onto a Vydac C18 reverse phase column and 
Empower 2 software (Waters, Milford, MA) was used for peak detection.  A dual buffer 
mobile phase (Buffer A: 50 mM NaH2PO4 and 10mM heptanesulfonic acid at pH 3.2; 
Buffer B: acetonitrile) was used with a flow rate of 1 ml/min and run time of 30 minutes.  
Fraction collection and liquid scintillation counting was used to determine DPM of SAM 
and a standard curve was used to quantify SAM and SAH.   
A.5 Determination of Tissue and Plasma amino acid concentrations and Methionine 
DPM 
Amino acid concentrations were determined by a modified method of Nyachoti et al. 
(2000).   
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A.5.1Tissue  Preparation 
Tissue was homogenized in cold perchloric acid (1:3 wt/vol) and centrifuged at 3000 x g 
for 15 minutes followed by decanting of supernant into a scintillation vial.  This step was 
repeated 3 times to total 1:9 wt/vol.  Norelucine was added to the scintillation vial as an 
internal standard and the pellet remaining in the tube was used for tissue bound amino 
acid analysis.  
A.5.2 Tissue Free Preparation 
K2CO3 (2.0 M) was added to supernatant (0.125:1) in a plastic test tube which was mixed 
and centrifuged at 3000 rpm for 3 minutes.  Using a syringe filter, 1 ml of supernant was 
added to another plastic test tube which was flash frozen in liquid nitrogen and placed on 
a freeze dryer overnight followed by derivatization.   
A.5.3 Tissue Bound Preparation 
The pellet was resuspended in 1.0 M NaOH (1:8 wt/vol) and the tube was covered with 
parafilm and mixed.  Protein was solubilized by adding tubes to a 37 
o
C water bath for 
~1.5 hours or until clear.  Protein was recovered by adding ½ volume of cold 20% 
perchloric acid and mixing tubes.  Samples were then placed on ice for 20 minutes 
followed by centrifugation at 2000 g for 15 minutes.  Supernant was discarded and 
norelucine was added as an internal standard.  HCl (6.0 M) was added to the tube (10 
ml/g tissue wt) and a glass rod was used to disrupt the pellet followed by transferring all 
contents to a Pyrex tube which was capped and placed in a 110 
o
C oven for 24 hours.  
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Tubes were then removed and left to cool overnight. Hydrolysates were mixed by 
inversion and transferred to pre-weighed Erlenmeyer flasks using size 4 or size 54 filter 
paper and a small funnel.  Tubes were rinsed twice with HPLC water and flasks were 
brought to a final volume of 25:1 (vol/original tissue wt).  1.0 ml was then transferred into 
a plastic tube via a 0.45 um syringe filter and tubes were placed in a vacuum oven 
overnight which was followed by derivatization.  
A.5.4 Plasma Analysis 
100 uL of plasma was mixed with 1 ml TFA (0.5% TFA in methanol) and norleucine was 
added as an internal standard.  Samples were vortexed and centrifuged at 5000 rpm for 5 
minutes and then poured into 3 ml test tubes. Samples were then flash frozen with liquid 
nitrogen to dry down overnight.  
A.5.5 Derivatization 
100 ul of 2:2:6 TEA:MeOH:water was added to tubes followed by freeze drying for 1 
hour.  50 ul of  1:1:1:7 TEA:PITC:Water:Methanol was added and tubes were left at room 
temperature for 35 minutes followed by flash freezing with liquid nitrogen and freeze 
dryer overnight.  Samples were resuspended in diluent (710 mg Na2HPO4 into 1 L of 
water. pH to 7.3 with H3PO4. Replace 5% of the volume with acetonitrile) and following 





A.5.6 Amino Acid HPLC 
40 ul of sample was injected onto a Waters C18 Pico-Tag column (Waters, Milford, MA)  
connected to an HPLC.  Amino acids were eluted using a dual buffer system of buffer A 
(70 mM sodium acetate and 2.5% acetonitrile at pH 6.55) and buffer B (45% acetonitrile 
and 15% methanol).  Peaks were determined using Empower 2 software (Waters, 
Milford, MA) and a fraction collector was used to isolate methionine, followed by liquid 
scintillation counting to determine DPM.   
A.6 Cystathionine  
Tissue cystathionine was analyzed according to the method of Seo et al. (2005).  70 mg of 
tissue was homogenized in 0.5ml borate buffer (0.025 mM pH 9.5 w 2 mM EDTA) 
followed by addition of 50 ul of tris-(2-carboxyethyl)phosphine (100 mg/ml).  Samples 
were mixed and left at room temperature for 30 minutes.  Protein was precipitated with 
2% PCA and centrifuged for 5 minutes at 3000 RCF.  Supernant was transferred to a new 
tube and 113 ul of 2 M K2CO3 was added followed by centrifugation for 5 minutes at 
3000 rpm.  Samples were flash frozen in liquid nitrogen and dried down overnight 
followed by resuspension in 300 ul of 0.1 M HCl.  Samples were then Derivatized 
according to Waters AccQ-Tag Derivatization kit (Waters, Milford, MA).  HPLC was 
used for separation of cystathionine following injection of Derivatized sample onto a 
AccQ-Tag HPLC column.  A dual buffer system (Buffer A: AccQ•Tag Eluent A 
Concentrate (Waters); Buffer B: Acetonitrile) was used with a flow rate of 1ml/minute 
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with a run time of 30 minutes.  Empower 2 software (Waters, Milford, MA) was used for 
peak detection. 
A.7 Tissue and Plasma Creatine and Guanidinoacetate (GAA) 
Tissue and plasma creatine and GAA were determined according to the method of 
Buchberger and Ferdig (2004).   
A.7.1 Tissue Creatine and GAA 
A ceramic mortar and pestle were used to grind tissues under liquid nitrogen and 50 mg 
tissue was placed in a centrifuge tube followed by 2 ml of 1.0 M perchloric acid.  
Samples were homogenized on ice and centrifuged at 4 
o
C for 20 minutes at 12,750 RPM.  
Supernatant was poured into a glass tube while recording weight of liquid.  50 ul of 50% 
K2CO3 and 20 uL of universal indicator were added to each tube followed by vortexing.  
250 ul of 20% KOH was added to neutralize (pH 6.5-7) and samples were again vortexed 
and left on ice for 10 minutes.  Samples were poured into labeled centrifuge tubes and 
centrifuged again for 10 minutes at 10,000 rcf at 4 
o
C.  Supernatant was poured into a 
new glass tube and liquid weight was recorded.  
A.7.2 Plasma Creatine and GAA 
14 ul of 30% perchloric acid was added to 200 ul of plasma and samples were vortexed 
and placed on ice for 15 minutes followed by centrifugation at 15,000 g for 8 minutes.  
150 ul of supernant was transferred to a new tube and 7.5 ul of K2CO3 and 22 ul of 20% 




A.7.3 Derivatization with Ninhydrin 
Derivatization for tissue samples (ratio adjusted for plasma) was then carried out by 
adding 300 ul of 1.3 M KOH and 150 ul of 0.9% Ninhydrin to 400 ul of sample in a glass 
tube which was then mixed and left at room temperature for 15 minutes.  100 ul 5% 
ascorbic acid and 100 uL phosphoric acid were then added to samples which were again 
mixed, capped with marbles and incubated in a 90 
o
C water bath for 30 minutes.  Tubes 
were cooled and samples were filtered using a 0.45 um syringe filter.  Metabolites were 
quantified via HPLC following injection onto a C18 Hypersil ODS 150x4.6 column and 
Empower 2 software was used for peak detection (Waters, Milford, MA).  A dual buffer 
system was used (Buffer A: 50 mM Formic Acid and Buffer B: 100% Methanol).   
A.8 Plasma Homocysteine and Cysteine 
Plasma homocysteine was determined using a modified method by Vester and Rasmussen 
(1991).  150μL of plasma was combined with 20 μL of tris-(2-carboxyethyl)phosphine 
(100mg/ml) which was vortexed and left at room temperature for 30 minutes.  50 ul of 0.2 
mM 8-amino-naphthalene-1,3,6-trisulfonic acid disodium salt (ANTS) (dissolved in 0.1 
mM borate buffer with 2 mM EDTA at pH = 9.5) and 125 uL of 0.6 M perchloric acid 
were added to samples which were left at room temperature for 10 minutes followed by 
centrifugation at 4° C at 6000 rpm for 5 minutes. 100 μL of supernatant was then 
transferred to dark Eppendorf tubes followed by addition of 200 μL of borate buffer (2 M 
at pH = 10.5) and 100 μL of derivatizing agent 7-fluorobenzo-2,1,3-oxadiazole-sulfonic 
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acid ammonium salt (SBD-F) solution (1 mg/mL SBDF in 0.1 M borate buffer with 2 
mM EDTA at pH = 9.5). Samples were covered in aluminum foil and vortexed followed 
by incubation at 60°C in a waterbath for 60 minutes.  Samples were then removed and 
placed on ice for 5 minutes followed by centrifugation at 7000 rpm for 5 minutes.  
Samples were injected into a Waters YMC column (Milford, MA) and homocysteine and 
cysteine were separated via reverse phase HPLC using a dual buffer system (Buffer A: 
and Buffer B:) with a run time of 20 minutes at 1 mL/minute.  Internal standard ANTS 
was used for quantification and Empower 2 software (Waters, Milford, MA) was used to 
determine area under the curve.  
Buffer Solution Preparation: 
Solution 1: Dissolve 6.8 g of sodium acetate trihydrate in 500 mL of HPLC water 
Solution 2: Add 11.5 mL glacial acetic acid (99.9%, 17.4 M) to 2 L of HPLC water 
Solution 3:Add Solution 1 for Solution 2 until pH = 4.0 (approximately 400 mL) 
HPLC Buffer A: Combine 980 mL of Solution 3 with 20 mL of methanol 
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